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Summary 
 
 
 
The quantification of differences between two or more states, physiological or 
pathological, in order to identify differentially expressed analytes in complex 
mixtures is among the most important objectives of proteomics and metabolomics.  
Mass spectrometry (MS) is one of the key analytical technology on which the 
emerging ‘‘-omics’’ approaches are based. It may provide detection and quantization 
of thousands of proteins and biologically active metabolites from a tissue, body fluid 
or cell culture working in a ‘‘global’’ or ‘‘targeted’’ manner, down to ultra-trace 
levels.  
Selected reaction monitoring (SRM) performed on triple quadrupole mass 
spectrometers has been actually the reference quantitative technique to analyze 
different molecules with high selectivity, sensitivity and a wide dynamic range. In 
SRM analysis, two stages of mass selection, i.e., selection of a precursor ion and 
monitoring of specific product ion(s) derived from the precursor, provide the highest 
analytical specificity applicable to complex mixture analysis.  
 The combination of m/z setting for the first and third quadrupole is referred to as 
‘transition'.  
New methodologies for selective quantitative  analysis of targeted metabolites and 
proteins based on LC-MS/MS in Selected Reaction Monitoring scan mode. are 
developed. This approach has shown to be a valuable tool to identify altered 
pathways in pathological conditions  and useful for quantitative measurements of a 
specific subset of known analytes such as same hormone and TDC, oxylipins, H2S 
sulfur metabolites, D, L Asp and NMDA and proteins as IDE and TSH. 
The SRM strategies optimized in this thesis focused on 1) identification of a set of 
proteins and metabolites of interest capable of satisfying a specific biological or 
clinic request 2) selection of transitions maximizing sensitivity and selectivity 3) 
optimization of SRM transitions by tuning acquisition parameters of the mass 
spectrometer 4) validation of the transitions in biological matrix to account to 
unspecific contributions of fragment ions background  5) quantification by the 
external standard method with the realization of specific calibration curves. 
The analysis in SRM mode (Selected Reaction Monitoring), has allowed us to 
achieve the specificity and selectivity to quantify the analytes of interest in relatively 
complex matrices, also at very low concentration with good reproducibility and 
accuracy. 
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1 Introduction 
 
1.1  Omics and system biology  
 
‘Omic’ technologies adopt a holistic view of the molecules that make up a cell, 
tissue or organism. They are aimed primarily at the universal detection of genes 
(genomics),mRNA (transcriptomics), proteins (proteomics) and metabolites 
(metabolomics) in different biological compartments such as whole blood, plasma 
and urine. The integration of these techniques is called systems biology (Horgan RP, 
2011).  
Systems biology is based on the understanding that the whole is greater than the sum 
of the parts. It has been responsible for some of the most important developments in 
the science of human health and environmental sustainability (Kitano, 2002). It is 
a holistic approach to deciphering the complexity of biological systems integrating 
many scientific disciplines – biology, computer science, engineering, bioinformatics, 
physics and others – to predict how these systems change over time and under 
varying conditions, and to develop solutions to the world’s most pressing health and 
environmental issues. 
Components data yield information regarding the specific molecular content of the 
cell or system. Interactions data specify the connectivity that exists among the 
molecular species, thereby defining the network 'scaffold' within the cell or system. 
Finally, functional-states data reveal the overall behaviour, or phenotype, of the cell 
or system (Joyce A. R. 2006). 
This ability to design predictive, multiscale models enables our scientists to discover 
new biomarkers for disease, stratify patients based on unique genetic profiles, 
and target drugs and other treatments. Systems biology, ultimately, creates the 
potential for entirely new kinds of exploration, and drives constant innovation in 
biology-based technology and computation.  (Hartwell LH1, 1999) 
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1.1.1 Components data  
 
Genomics. Genomics is defined as the study of the whole genome sequence and 
the information contained therein. It is clearly the most mature of the omics-sciences. 
Since 1995, nearly 300 genome-sequencing projects, with representative species 
from each of the three kingdoms of life, have been completed (Liolios 2006)
 
and 
hundreds more are underway.  
The genomic sequence is used to study the function of the numerous genes 
(functional genomics), to compare the genes in one organism with those of another 
(comparative genomics), or to generate the 3-D structure of one or more proteins 
from each protein family, thus offering clues to their function (structural genomics). 
Genome annotation provide information about human and other major model 
organisms on complement of proteins and functional RNAs, transcription-factor-
binding sites in genomic sequences and on complete set of translated open reading 
frames (ORFs) and the exon-intron structures from which they are assembled.  
 
Transcriptomics. The transcriptome is the total mRNA in a cell or organism and 
the template for protein synthesis in a process called translation. The transcriptome 
reflects the genes that are actively expressed at any given moment (Horgan RP 
2011). Microarrays and serial analysis of gene expression (SAGE)
 
represent the most 
well-used approaches and have been applied to many model systems, as well as to 
the study of genes that are predominantly expressed in stem cells, to classifying the 
molecular subtypes of human cancers, and to monitoring the host-cell transcriptional 
response to pathogens
 
(Joyce A. R. 2006). 
 
Proteomics. The proteome is defined as the set of all expressed proteins in a cell, 
tissue or organism. Proteome analysis presents specialized analytical problems in two 
major areas: i) dynamic expression range and ii) diversity of protein expression 
(multiple protein forms). In order to clarify proteome–phenotype relationships, 
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several studies are dedicated to the development of new technology to explain the 
link between protein-expression profiles and distinct cellular processes or conditions  
(Kuster 2005). In particular, one strategy that is being developed involves 
overcoming the problem of detecting only the most highly represented proteins in 
biological samples by focusing on unique characteristic peptides for each protein or 
protein isoform  (Joyce A. R. 2006). 
 
 
Metabolomics. The metabolome refers to the complete set of low molecular 
weight compounds in a biological sample. These compounds are the substrates and 
byproducts of enzymatic reactions and have a direct effect on the phenotype of the 
cell. Metabolites are the final products of the genome, transcriptome and proteome 
integration.  The metabolome consists of molecules that have high chemical and 
physical heterogeneity. Metabolomics is fast becoming a popular tool for studying 
the cellular state of many systems, including plants, the human red blood cell and 
microbes, as well as in metabolic-engineering applications, in pharmacology and 
toxicology and in human nutritional studies (Joyce A. R. 2006). 
 
Lipidomics. Lipidomics is the systems-level analysis of lipids (fat molecules) and 
their interactions. It is a science still in its infancy but one that promises to 
revolutionize biochemistry. Lipids are grouped into eight categories that share 
common physical and chemical properties, and there are currently some 38,000 
documented lipids (German, 2007). 
Lipids that occur rarely or in small quantities are often the most effectual lipids in 
biological processes, meaning they are particularly important in disease diagnostics 
and in understanding pathology. Lipidomics can elucidate the pathology and 
treatment of many diseases such as cancer, diabetes, obesity, cardiovascular disease, 
arthritis, asthma, inflammatory bowel disease, Alzheimer's and others due to the 
associated disruption of lipid metabolic enzymes and pathways. A better 
understanding of lipidomics could significantly advance diagnostic medicine as well 
as provide novel treatment options (Rob Smith, 2014). 
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1.2 Mass spectrometry 
 
Mass spectrometry is a reproducible methodology based on the determination 
of the molecular mass, which is not dependent on the experimental conditions. Most 
important features of mass spectrometry are: reproducibility, sensitivity, accuracy.  
Mass spectrometry is based on the production of gas phase ions. These ions can 
interact with an electric field and can be resolved following their electro-dynamic 
attitude, which is dependent on their mass-to-charge ratio. 
Today a wide variety of mass spectrometers is available, all sharing the capability to 
assign mass-to-charge values to ions, although the principles of operation and the 
types of experiments that can be done on these instruments differ greatly. 
Mass spectrometers have four essential parts:  
a) system for sample introduction 
 b) source that produces gas phase ions from the sample  
 c) one or more mass analyser to separate ions 
 d)  ion detector. 
Sample under investigation has to be introduced into the ion source of the instrument 
where the sample molecules are ionized. These ions are extracted into the analyser 
region of the mass spectrometer where they are separated according to their mass-to-
charge ratios (m/z). The separated ions are detected and the generated signals sent to 
a data system where the m/z ratios are stored together with their relative abundance 
for presentation in the format of an m/z spectrum (Fig. 1.1). 
  
 
 
 
 
 
 
 
 
      Figure 1.1 Process of measuring of a mass spectrometer 
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A class of mass spectrometers can be distinguished on its ionization system and on 
the type of analyser, that is an essential component to define the accessible mass 
range, sensitivity and resolution.  
All mass spectrometers are operated at very low pressure in order to prevent 
collisions of ions with residual gas molecules in the analyser during the flight from 
the ion source to the detector.  
Many ionization methods are available however the most widespread ionization 
methods in biochemical analyses are Electrospray Ionization (ESI) and Matrix 
Assisted Laser Desorption Ionization (MALDI). Mass analysers as quadrupoles (Q), 
ion traps (IT), time-of-flight (TOF), or combination of these in “hybrid instruments”, 
are commonly used for their good resolution and sensitivity. TOF analysers are 
typically used in combination with MALDI sources (MALDI-TOF MS instruments); 
however both MALDI sources and TOF analysers can be used in different 
configuration. 
The coupling of Liquid Chromatography (LC) and tandem Mass Spectrometry 
(MS/MS) is a widely used analytical technique for quantitative and qualitative 
analysis. Electrospray Ionization (ESI), Atmospheric Pressure Chemical Ionization 
(APCI), or Photo Ionization (APPI) allow the ionization of various semi-volatile, 
thermally labile, and polar to non polar compounds, such as pharmaceuticals, 
pesticides, personal care products, steroids, explosives, drugs of abuse etc., in trace 
levels. Generated ions will be transferred after ionization through a vacuum interface 
into the mass analyzer. 
 
1.2.1 Electrospray (ESI) 
 
Electrospray Ionization (ESI) has had a tremendous impact over the last few years 
on the use of mass spectrometry in biological research. ESI is well suited to the 
analysis of polar molecules ranging from less than 100 Da to more than 1,000,000 
Da in molecular weight. In contrast to MALDI, in which the sample is a dried, 
crystalline admixture of protein/peptide sample and matrix, the peptides or proteins 
to be analyzed by ESI are in aqueous solution. Proteins and peptides exist as ions in 
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solution because they contain functional groups whose ionization is controlled by the 
pH of the solution. 
During standard electrospray ionization sample is dissolved in a polar, volatile 
solvent and pumped through a narrow, stainless steel capillary (Fig. 1.2). A high 
voltage of 3 or 5 kV is applied to the tip of the capillary situated within the ionization 
source of the mass spectrometer and the sample emerging from the tip is dispersed 
into an a spray of highly charged droplets, a process that is aided by a co-axially 
introduced nebulising gas flowing around the outside of the capillary.  
 
Figure 1.2  ESI source 
 
This gas, usually nitrogen, helps to direct the spray emerging from the capillary tip 
towards the mass spectrometer. The charged droplets diminish in size by solvent 
evaporation, assisted by a warm flow of nitrogen known as the drying gas which 
passes across the front of the ionization source.  
Eventually charged sample ions, free from solvent, are released from the droplets, 
some of which pass through a sampling cone or orifice into an intermediate vacuum 
region, and from there through a small orifice into the analyser of the mass 
spectrometer, which is held under high vacuum.  
Electrospray is known as a “soft” ionization method (such as MALDI) as the sample 
is ionized by the addition or removal of a proton, with very little extra energy 
remaining to cause fragmentation of the sample ions. 
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The peculiar aspect of this technique is the fact that it gives rise to multiply charged 
molecular-related ions such as (M+nH)
n+ 
in positive ionization mode and (M-nH)
n-
 in 
negative ionization mode. Because of the form assumed by the signal, this source is 
not useful to the analysis of complex mixtures. For this reason RP-HPLC system is 
generally coupled to ESI-source.  
ESI source generally works with quadrupole and ion trap analyzers.  
 
1.2.2 Quadrupole (Q) mass analyser 
 
Quadrupole mass analyser (Fig. 1.3) has now become one of the most widely used 
types of mass analyser because of its ease of use, small size and relative low cost. It 
consists of four parallel rods that have fixed DC and alternating RF potentials applied 
to them. Ions produced in the source of the instrument are then focused and passed 
along the middle of the quadrupoles. Their motion will depend on the electric fields 
so that only ions of a particular m/z will be in resonance and thus pass through to the 
detector following a stable trajectory. 
 
 
   Figure 1.3  Quadrupole mass analyser 
 
All other ions do not have a stable trajectory through the quadrupole mass analyzer 
and will collide with the quadrupole rods, never reaching the detector. The RF is 
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varied to bring ions of different m/z into focus on the detector and thus build up a 
mass spectrum.  
 
 
1.2.3  Tandem mass spectrometry 
 
Tandem mass spectrometry (MS/MS) is used to produce structural information 
about a compound by fragmenting specific sample ions inside the mass spectrometer 
and identifying the fragment ions. Tandem mass spectrometry also enables specific 
compounds to be detected in complex mixtures on account of their specific and 
characteristic fragmentation patterns. Tandem mass spectrometry uses two stages of 
mass  analysis, one to preselect an ion and the second to analyze fragments. 
Generally in a tandem mass spectrometer the two analysers are separated by a 
collision cell into which an inert gas (e.g. argon, xenon) is admitted to collide with 
the selected sample ions and bring about their fragmentation.   
 
1.2.4 Instruments for MS/MS analysis 
 
Instruments for tandem mass spectrometry can be classified as tandem in space or 
tandem in time (Fig. 1.4). Tandem in space means that ion selection, ion 
fragmentation and fragments analysis, are events that occur in three different regions 
of the spectrometer; instruments of this type are the triple quadrupole (ESI-QqQ) and 
hybrid instruments such as ESI-Q-TOF, ESI-QqLIT or MALDI-TOF-TOF. In 
tandem in time instruments, those three steps of analysis occur  in the same region of 
the spectrometer but in different times; three-dimensional ion trap are instruments 
classified as tandem in time. 
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Figure 1.4 Schematic representation of tandem-in-space and tandem-in-time 
instruments 
A commonly used instrument is the triple quadrupole, where two resolving 
quadrupoles mass filters are separated by a fragmentation cell. These are considered 
to be “beam-type” mass spectrometers because they are most often used with a 
continuous ion beam: when one of the mass filters is scanning, most of the ions are 
rejected by the instrument, resulting in poor sample use and low sensitivity, whereas 
when the mass filters are not scanning, but are transmitting a pre-selected ion, 
sensitivity and sample use are very high. MSMS mass spectrometer are Quadrupole 
ion Trap, Linear ion trap and triple quadrupole. 
 
 
1.2.5 Quadrupole ion trap (IT) 
 
The quadrupole ion trap is based on the same principle as the quadrupole mass 
filter, except that the quadrupole field is generated within a three-dimensional trap. 
The trap consist of three electrodes, a ring electrode and two hemispherical end caps 
electrodes. These electrodes allow to trap ion in a small volume (Fig. 1.5).  
In quadrupole ion traps, ions are dynamically stored in a three-dimensional 
quadrupole ion storage device. The RF and DC potentials can be scanned to eject 
successive mass-to-charge ratios from the trap into the detector. 
Ions are injected into an ion trap from an external source. Ions are dynamically 
trapped by the applied RF potentials. The trapped ions can be manipulated by RF 
events. 
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    Figure 1.5  Quadrupole ion trap 
 
The advantages of the ion-trap mass spectrometer include compact size, and the 
ability to trap and accumulate ions to increase the signal-to-noise ratio of a 
measurement. For these reasons ion traps are used in fragmentation experiments. 
Conventional ion trap mass spectrometers operate with a three-dimensional (3D) 
quadrupole field, which confers to the analysis very high efficiency as regard the 
time to fill the ion trap and to generate a complete mass spectrum, but presents some 
problems as regard the trapping efficiencies, primarily due to their small volume. 
These problems have been overcome thanks to the introduction of linear ion traps, 
characterized by a larger ion storage capacity and a higher trapping efficiency. 
 
1.2.6 Linear ion trap (LIT) 
 
Trapping of ion can also be performed in linear 2D ion trap devices(LIT) (Le 
Blanc et al., 2003). The combination of triple quadrupole MS with LIT technology in 
a form of an instrument of configuration QqLIT (Fig. 1.6), is particularly interesting 
because this instrument retains the classical triple quadrupole scan functions such as 
selected reaction monitoring (SRM), product ion (PI), neutral loss (NL) and 
precursor ion (PI) while also providing access to sensitive ion trap experiments. In 
addition, for peptide analysis, the enhanced multiply charged (EMC) scan allows an 
increase in selectivity, while the time- delayed fragmentation (TDF) scan provides 
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additional structural information. The first commercially available instruments (Q-
Trap 
TM
) was manufactured by SCIEX and made available through the commercial 
area of Applied Biosystem. 
 
 
Figure 1.6  Schematic representation of QqLIT mass analyser 
 
Ions generated by an ESI source, travel through an RF-only quadrupole (Q0) (that is 
used to collisionally cool the incoming ion beam) before entering in the first 
quadrupole Q1, that is a conventional RF/DC quadrupole mass filter and is tuned to 
transmit only the precursor ion of interest towards the second quadrupole (q2), that is 
a collision cell. The final quadrupole , Q3, can be operated as either another RF/DC 
mass filter or a linear ion trap with mass-selective axial ejection. Switching from 
triple-quadrupole to ion-trap modes is accomplished by changes in electrical voltages 
can be applied in < 1 ms. This means that analytical workflow can be devised that 
use both triple-quadrupole and ion-trap on a chromatographic timescale.  
Linear ion trap combines the advantages of a triple quadrupole (very selective 
scanning of precursor ions) with that of three-dimensional ion trap, like high 
sensitivity. LITs have two major advantages over 3D-IT: a larger ion storage 
capacity and a higher trapping efficiency. Moreover there is no inherent low-mass 
cut-off in the product ion spectra because the fragmentation and the ion-trapping 
steps are spatially separated, while in conventional 3D ion traps the precursor and the 
lowest mass fragment must be stable simultaneously in the trap, which produces a 
low-mass cut-off in the resulting spectrum at about 25-30% of the precursor ion m/z.  
Using Q3 as a linear ion trap mass spectrometer it is also possible to obtain MS
n
 
spectra, taking advantage of the characteristics of  higher trapping efficiency of LIT 
upon 3D-IT and reduced space-charge interactions that limit the number of ions that 
can be stored. Moreover Q3 is operated at a very low pressure (3*10
-5
 Torr) that 
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insure that the ions entering the Q3 trap are collisionally cooled thereby enhancing 
trapping efficiency and sensitivity of MS
n
.    
This instrument can operate in different scan modes (Fig1.7): 
a) In the product or daughter ion scanning the Q1 is used to select user-specified 
sample ions arising from a particular component; usually the molecular-related (i.e. 
(M+H)
+
 or (M-H)
-
) ions. These chosen ions pass into the q2, are bombarded by the 
gas molecules which cause fragment ions to be formed, and these fragment ions are 
analysed (i.e. separated according to their mass to charge ratios) by the Q3. All the 
fragment ions arise directly from the precursor ions specified in the experiment, and 
thus produce a fingerprint pattern specific to the compound under investigation.  
This type of experiment is particularly useful for generating peptide sequence 
information.  
b) In the precursor or parent ion scanning the Q1 allows the transmission of all 
sample ions, while the Q3 is set to monitor specific fragment ions, which are 
generated by bombardment of the sample ions with the collision gas in the q2. This 
type of experiment is particularly useful for monitoring groups of compounds 
contained within a mixture which fragment to produce characteristic fragment ions.  
c) In the constant neutral loss scanning both the Q1 and Q3 scan and collect data 
across the whole m/z range, but the two are off-set so that the second analyser allows 
only those ions which differ by a certain number of mass units (equivalent to a 
neutral fragment) from the ions transmitted through the first analyser. This scan 
mode is used, for example, to identify phosphorilated peptides in a peptide mixture. 
In fact a typical fragmentation of these peptides consists of the loose of a phosphoric 
acid residue, with a mass shift of  -98 Da.  
Other typical scan modes are the enhanced multiply charged scan and time-delayed 
fragmentation. The enhanced multiply charged mode allows the removal of singly 
charged ions from the LIT (due to sample impurities), while doubly charged ions are 
enhanced in resolution and sensitivity. Time-delayed fragmentation mode is 
particularly interesting for spectra interpretation because it reduces multiple 
sequential fragmentations and so leads to simpler tandem mass spectra. This is 
obtained by eliminating ions with a kinetic energy over a threshold that don’t 
fragment correctly.   
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The most common usage of MS/MS in proteomics is the product or daughter ion 
scanning experiment which is particular successful for peptide sequencing. 
 
 
 Fig 1.7  Different scan modes 
      
1.2.7     Triple quadrupole 
Single quadrupole systems contain only one mass filtering quadrupole while triple 
quadrupole systems consist of three quadrupoles. Q1 and Q3 are working as mass 
filters while Q2 is acting as collision cell.  
Quadrupoles can be used in scanning or filtering mode. During a mass scan, DC and 
RF voltages are ramped resulting in the acquisition of full scan mass spectra. Such 
spectra are typically used for qualitative data analysis. However, scanning a 
quadrupole suffers from low sensitivity and slow scan speed. Thus, quantitative 
studies are performed with quadrupoles working in filtering mode. The most 
selective mode to use a single quadrupole MS is called Selected Ion Monitoring 
(SIM). Hereby, a fixed set of DC and RF voltages is applied to the quadrupole and 
thus only a single m/z can pass. Ions with different m/z are filtered out.  
A fundamental understanding of the scan modes associated with the TQMS is 
essential for understanding the MS and MS/MS capabilities of the instrument. 
(March, 2009). 
The triple quadrupole tandem mass spectrometer can readily be used to perform a 
single stage of mass spectrometry (MS) by setting two of the three quadrupoles into 
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RF-only (total ion) mode. Either Q1 or Q3 can be used as a mass filter, scanned to 
obtain a full spectrum, or set to pass a single fixed m/z (or a few fixed m/z values), a 
mode termed selected ion monitoring (SIM). When Q1 and Q3 are both used as mass 
analyzers, there are four possible MS/MS scan modes. In the daughter ion scan mode 
(also called product ion scan), Q3 is scanned to obtain a spectrum of all the daughter 
ions generated by CID in q2 of the parent or precursor ion mass-selected with Q1. In 
the parent ion scan mode (also called precursor ion scan), Q1 is scanned to obtain a 
spectrum of all the parent ions that upon CID in q2 produce the daughter or product 
ion mass-selected with Q3. In a neutral loss scan, both Q1 and Q3 are scanned at the 
same rate but with a fixed difference in mass to detect only those ions that undergo a 
specific neutral loss in q2 such as a loss of mass 18 (H2O). An important MS/MS 
scan mode for quantitating targeted compounds with maximum sensitivity is the 
selected reaction monitoring mode (SRM) in which one (or a few) selected parent-
ion-to-daughter-ion transitions are monitored by setting Q1 and Q3 to pass specific 
m/z values. SRM is the MS/MS scan mode analogous to the MS selected ion 
monitoring scan mode (SIM). 
Selected Reaction Monitoring (SRM) is the most common mode of using a triple 
quadrupole MS/MS for quantitative analysis, allowing enhanced sensitivity and 
selectivity. The first quadrupole filters a specific precursor ion of interest. Ions 
generated in the ion source having a different m/z can not pass Q1. The collision cell 
is optimized to produce a characteristic product ion by collision of the precursor ion 
with a neutral collision gas, such as nitrogen. This process is called Collision Induced 
Dissociation (CID). Generated product ions are transferred into the third quadrupole 
where only a specific m/z is allowed to pass. All other product ions are filtered out in 
Q3. In SRM mode, two stages of mass filtering are employed on a triple quadrupole 
mass spectrometer. In the first stage, an ions of interest (the precursor) is preselected 
in Q1 and induced to fragment by collisional excitation with a neutral gas in a 
pressurized collision cell (Q2). In the second stage, instead of obtaining full scan 
ms/ms where all the possible fragment ions derived from the precursor are mass 
analyzed in Q3, only a small number of sequence-specific fragment ions (transition 
ions) are mass analyzed in Q3. 
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Fig 1.8 Selected ion mode  
 
Thus SRM mode works like a double mass filter which drastically reduces noise and 
increases selectivity. Single quadrupole and triple quadrupole systems allow the 
detection of many SIM and SRM transitions, respectively. This enables quantitation 
of many targeted analytes in a single experiment. Typically, additional SIM and 
SRM transitions have to be detected to perform identification of quantified 
compounds. Hereby, the most intense ion is called the ‘quantifier’ and all additional 
ions are called ‘qualifiers’. The EU Commission Decision 2002/657/EC defined 
performance criteria for confirmatory methods, such as MS and MS/MS, by 
introducing the concept of identification points. The required number of 4 
identification points can be achieved by detecting 4 SIM on a single quadrupole MS 
or 2 SRM transitions on a triple quadrupole MS/MS. This targeted MS analysis using 
SRM enhances the lower detection limit for peptides by up to 100 fold (as compared 
to full scan ms/ms analysis) by allowing rapid and continuous monitoring of the 
specific ions of interest. 
Selected reaction monitoring (SRM) coupled with stable isotope dilution mass 
spectrometry (SID-MS) using a triple quadrupole mass spectrometer is a powerful 
method for quantitative measurement of target molecules.. SRM methods, in 
principal, provide both absolute structural specificity for the analyte and relative or 
absolute measurement of analyte concentration when stable, isotopically-labeled 
standards are added to a sample in known quantities. When a synthetic, stable isotope 
labeled peptide is used as an internal standard, the concentration can be measured by 
comparing the signals from the exogenous labeled and endogenous unlabeled 
species. This can be done because they have the same physicochemical properties 
and differ only by mass. It has been a principal tool for quantification of small 
molecules in clinical chemistry for number of decades. MS-based quantitative assays 
have the necessary characteristics required for verification studies, namely: high 
specificity, sensitivity, multiplexing capability, and precision. 
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1.3 Mass spectrometry based omics 
 
Dramatic technological advances in the biological sciences over the past few 
years have forged a new era of research including the emerging field of systems 
biology. Although the understanding of living organisms at the molecular system 
level is still in its infancy, it is evident that comprehensive investigations of the 
“omics cascade” with genomics, transcriptomics, proteomics, and metabolomics are 
important building blocks and will play a central role in this new science (Dettmer, 
2007). 
 The integrative analysis of an organism’s response to a perturbation on the 
transcriptome, proteome, and metabolome levels will lead to a better understanding 
of the biochemical and biological mechanisms in complex systems. 
Many "omics" techniques have been developed for one goal: identification of 
specific target compounds involved in diagnosis, prognosis, therapeutic response 
prediction and population screening of human disease. For example, recent ‘‘omics’’ 
technologies have opened a new road to biomarker discovery and early detection of 
cancer. A biomarker is a biologically derived molecule in the body, which is 
indicative of the progress or status of a disease.  
Mass spectrometry (MS) is one of the key analytical technology on which the 
emerging ‘‘-omics’’ approaches are based. It may provide detection and quantization 
of thousands of proteins and biologically active metabolites from a tissue, body fluid 
or cell culture working in a ‘‘global’’ or ‘‘targeted’’ manner, down to ultra-trace 
levels. It can be expected that the high performance of MS technology, coupled to 
routine data handling, will soon bring fruit in the request for a better understanding 
of human diseases, leading to new molecular biomarkers, hence affecting drug 
targets and therapies. 
 
1.3.1 Mass spectrometry-based metabolomics 
 
Mass spectrometry-based metabolomics aims at the comprehensive and 
quantitative analysis of wide arrays of metabolites in biological samples having very 
diverse physico-chemical properties and occurring at different abundance levels. 
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Consequently, comprehensive metabolomics investigations are primarily a challenge 
for analytical chemistry and specifically mass spectrometry has vast potential as a 
tool for this type of investigation. Metabolomics require special approaches for 
sample preparation, separation, and mass spectrometric analysis. It primarily focuses 
on metabolic fingerprinting, a technique that analyzes all detectable analytes in a 
given sample with subsequent classification of samples and identification of 
differentially expressed metabolites, which define the sample classes 
Metabolome refers to the complete set of small-molecule metabolites (such as 
metabolic intermediates, hormones and other signalling molecules, and secondary 
metabolites) to be found within a biological sample, such as a single organism.  
Metabolites usually represents small molecular species subjected to temporal, spatial 
and diet variability. Metabolites are produced during metabolism or at its end. The 
metabolome term (coined in the late 1990s by S.G. Oliver et al.,1998) is highly in 
homogeneous, because it represents a vast number of components that belong to a 
wide variety of compound classes, such as amino acids, lipids, organic acids, 
nucleotides, etc. in a high dynamic range of concentrations. According to Beecher, 
two thousand major metabolites seem to be a good estimate for humans and this 
number could greatly increase if we consider also the secondary metabolites (Di 
Girolamo F., 2013). 
 
 
 The word was coined in analogy with “transcriptomics” and “proteomics”; like the 
transcriptome and the proteome, the metabolome is dynamic, changing from second 
to second. Although the metabolome can be defined readily enough, it is not 
currently possible to analyze the entire range of metabolites by a single analytical 
method. Each type of cell and tissue has a unique metabolic ‘fingerprint’ that can 
elucidate organ or tissue-specific information, while the study of biofluids can give 
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more generalized though less specialized information. Commonly used biofluids are 
urine and plasma, as they can be obtained non-invasively or relatively non-
invasively, respectively.  
 A metabolite is usually defined as any molecule less than 1 kDa in size.  In plant-
based metabolomics, it is common to refer to "primary" and "secondary" metabolites. 
A primary metabolite is directly involved in the normal growth, development, and 
reproduction. A secondary metabolite is not directly involved in those processes, but 
usually has important ecological function. Examples include antibiotics and 
pigments. By contrast, in human-based metabolomics, it is more common to describe 
metabolites as being either endogenous (produced by the host organism) or 
exogenous. Metabolites of foreign substances such as drugs are termed xeno 
metabolites. Global metabolic fingerprinting and quantitative metabolite profiling, 
represent two complementary strategies currently applied for metabolomic 
investigations  (Dettmer K, 2004). 
In most cases, the first step in a metabolite profiling experiment is to extract 
metabolites from the biological matrix. Extracted metabolites are often separated 
using gas chromatography/MS (GC/MS), liquid chromatography/MS (LC/MS), or 
capillary electrophoresis/MS (CE/MS). Critical to all MS-based approaches is the 
efficient desorption and ionization of metabolites, where the resulting gas phase ions 
can be separated by mass analyzers such as quadrupole, time-of-flight, and ion trap. 
Ions are typically detected using a microchannel plate and photomultiplier tube and 
identified through comparison of exact mass, retention time, and fragmentation 
information with genuine standards and spectral databases (Lee D.Y. 2010). 
Nowadays, high throughput LC/MS/SRM allows simultaneous analysis of different 
class of small molecules, metabolites, or drugs in a short time, therefore enabling a 
quantitative profiling of hundreds to thousands of samples for target based metabolite 
profiling (Wei R., 2010).  
Among different types of mass spectrometers, such as ion trap, time-of-flight, 
orbitrap, and quadrupole mass spectrometers, a triple quadruple mass spectrometer is 
optimal for targeted metabolomics, based on its high sensitivity, high specificity, and 
excellent quantitation ability. Two stages of mass selection reside in a triple 
quadrupole mass spectrometer: precursor ion (MS1) and a fragment of the precursor 
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ion (product ion, MS2) that produce a molecular weight and structure specific 
sensitive measurement for a given analyte. The potential power of utilizing a triple 
quadrupole mass spectrometry-based quantitation technique, namely, Selected 
Reaction Monitoring (SRM), for metabolomics has not been fully recognized until 
recently. A triple quadrupole mass spectrometry-based quantitation for small 
molecules has been heavily used by analytical chemists for analyzing drug 
metabolites,  hormones,  pesticides, and herbicides with great precision (CV < 
10%). To further increase selectivity and sensitivity of the triple quadrupole mass 
spectrometry-based quantitation assay, a front-end separation technique, such as LC, 
GC, or CE, is often added as the third dimension of separation. While a variety of 
separation techniques can be used to couple a triple quadrupole mass spectrometer, 
the polarity-based liquid chromatography (LC) stands out for its speed, simple 
sample pre-treatment, and numerous choices of types of commercially available 
columns based on different separation mechanisms such as reverse phase, normal 
phase, or hydrophilic interaction, etc  (Silas G. Villas-Boˆas 2005).  
Mass spectrometry-based metabolomics offers quantitative analyses with high 
selectivity and sensitivity and the potential to identify metabolites. Combination with 
a separation technique reduces the complexity of the mass spectra due to metabolite 
separation in a time dimension, provides isobar separation, and delivers additional 
information on the physico-chemical properties of the metabolites. However, mass 
spectrometry-based techniques usually require a sample preparation step, which can 
cause metabolite losses, and based on the sample introduction system and the 
ionization technique used, specific metabolite classes may be discriminated. 
Therefore, parallel application of several techniques, for example, GC-MS and LC-
MS is desired to study the metabolome comprehensively (Dettmer K, 2007).  
 
 
1.3.2  Mass spectrometry-based proteomics  
 
Recent successes illustrate the role of mass spectrometry-based proteomics as an 
indispensable tool for molecular and cellular biology and for the emerging field of 
systems biology.  Proteomics was defined as the study of “the expressed protein 
complement of a genome at a specific time” by Wilkins in 1994. The terms 
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“proteomics” and proteome” mirror the terms “genomics” and “genome”. The 
drivers of genomic and proteomic analyses are the technological achievements of the 
past decade that enable the quantitative analysis of the DNA sequence, mRNA and 
protein expression inside cells and include tools such as DNA microarrays, two-
dimensional gel electrophoresis (2D-GE) and mass spectrometry (MS).  
Nowadays proteomics can rely on powerful analytical protein-separation 
technologies (chromatography, electrophoresis), that serve to simplify complex 
protein mixtures to compare apparent differences in protein levels between two 
samples. However the most powerful analytical tools for proteomic analysis is mass 
spectrometry (MS), whose instrumentation has undergone huge changes over the past 
years, culminating in the development of highly sensitive, robust instruments that can 
reliably analyze biomolecules, particularly proteins and peptides. 
The introduction of ES and MALDI (1980’s), in combination with the accessibility 
of genome sequence information, has revolutionized MS, thus allowing routine MS 
analysis of protein molecules. Two main strategies for protein ID by MS are 
currently used in proteomics: top-down and bottom-up proteomics. In top-down 
proteomics, intact proteins are introduced into a mass spectrometer and then 
subjected to gas-phase fragmentation  (Di Girolamo F., 2013). 
However, the purpose to multiply charged product ions has always been a weak point 
of this approach, because it may prevent the determination of product ion masses. 
With the introduction of the modern mass spectrometers with high mass 
measurement accuracy, this obstacle has been overcome (e.g., modern MALDI 
TOF/TOF instruments). Conversely, in bottom-up proteomics, the proteins are firstly 
separated by gel electrophoresis or chromatography, subsequently digested by 
specific enzymes (e.g., trypsin to cut lysine and arginine) and then introduced into 
the mass spectrometer. Bottom-up proteomics approach is represented by peptide 
mass fingerprinting (PMF) and tandem MS analysis. PMF has largely characterized 
the early years of the proteomic era; it relies on the acquisition of mass spectra from 
a tryptic digest of a protein sample and on the measure of tryptic peptide masses 
searched against a protein database such as UniProt, employing different database 
search engines and performing, for each protein, an in silico tryptic digest, hence 
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generating a theoretical spectrum. The best overlap between the experimental and 
theoretical mass spectra then identifies the protein.  
The 1D- or 2D-SDS-PAGE-LC-MS/MS based proteomics, often called shotgun 
proteomics, is now the main bottom-up proteomics technological approach. The 
workflow provides the protein separation by 1D-SDSPAGE according to MW, 
followed by in-gel tryptic digestion, peptide analysis by nanoLC-MS/MS and protein 
ID by database searching, as above described (Evans V.C, 2012). While the 
application of shotgun proteomics workflows to tissues, cells, and organelles usually 
results appropriate, the analysis of body fluids (e.g., serum, blood, plasma, intestinal 
fluids, urine samples) is particularly difficult because of the complexity and of the 
high dynamic range of contained analytes.  
Recently, LC MS/MS in SRM ion mode has emerged as a promising technique for 
such precise quantification of targeted proteins. Originally applied to the 
measurement of small molecules (such as metabolites or drugs), where a capillary 
chromatography column is connected in-line to the electrospray ionization source of 
the mass spectrometer (Picotti P., 2012). SRM exploits the unique capability of triple 
quadrupole (QQQ) mass spectrometers to act as mass filters and to selectively 
monitor a specific analyte molecular ion and one or several fragment ions generated 
from the analyte by collisional dissociation. The number of such fragment ions that 
reach the detector is counted over time, resulting in a chromatographic trace with 
retention time and signal intensity as coordinates. Several such precursor–fragment 
ion pairs, termed SRM transitions, can be sequentially and repeatedly measured at a 
periodicity that is fast compared to the analyte's chromatographic elution, yielding 
chromatographic peaks for each transition that allow for the concurrent 
quantification of multiple analytes. This multiplexing capability has led to the term 
multiple reaction monitoring (MRM), which is frequently used as a synonym of 
SRM. When applied to proteomics, SRM measures peptides produced by the 
enzymatic digestion of a proteome as surrogates of the corresponding proteins. 
Molecular ions within a mass range centered around the mass of the targeted peptide 
are selected in the first mass analyzer (Q1), fragmented at the peptide bonds by 
collision-activated dissociation (in Q2) and one or several of the fragment ions 
uniquely derived from the targeted peptide are measured by the second analyzer 
27 
 
(Q3). A suitably chosen set of SRM transitions therefore constitutes a specific assay 
to detect and quantify a target peptide and, by inference, a target protein in complex 
samples ( Lange V., 2008). 
The application of SRM to proteomics has been slow and not without complications. 
Proteins are large molecules and by themselves at present are not compatible with the 
technique. The ensuing questions of how many and which of the many peptides 
generated by tryptic digestion of each target protein constitute optimal inputs for 
SRM assays are therefore of critical importance. In addition, peptides generally yield 
more complex fragment-ion patterns than metabolites or drugs, thus complicating the 
choice of appropriate SRM transitions  (Picotti P, 2012) 
 
1.3.3 SRM in clinical applications 
 
The capability of SRM to quantify specific target compounds across a variety of 
samples appears particularly well suited for biomarker verification. Candidate 
biomarkers for their respective disease need to be verified across large sample sets to 
achieve sufficient statistical power, targeting easily accessible human specimens, 
such as serum or plasma  (Rifai N, 2006). Classically, biomarker verification relied 
on antibody-based assays, but recently SRM has emerged as an alternative because 
of its superior multiplexing capabilities of 50–100 analytes, the shorter and cheaper 
assay development and the capability to discriminate between protein isoforms. 
 Numerous examples of the application of SRM for the analysis of low molecular 
weight chemicals with biological relevance exist in the literature and these span a 
broad range of analytes including endogenous compounds, therapeutic agents and 
their metabolites, environmental toxicants and compounds of abuse or malicious 
intent. Recent examples of the use of SRM for analysing endogenous compounds in 
humans include the measurement of vitamins, steroids and neurotransmitters, 
multipleanalyses of drugs and their metabolites are too numerous to list 
comprehensively, but include the measurement of therapeutic agents, such as 
warfarin, triazolam, nevirapine and antibiotics, the measurement of drugs of abuse, 
such as heroin, cocaine and cannabinoids and the assay of performance enhancers, 
such as androgen and other stimulants. In addition, SRM has been utilised for the 
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analysis of low molecular weight chemicals present in plants, fish and contaminated 
water courses, demonstrating the versatility and breadth of application of the 
technique for the routine quantification of low molecular weight products 
(Kitteringhama, 2009). 
Over the last ten years, several studies that applied SRM to protein analysis increased 
exponentially and the subject of such studies is progressively shifting from 
technological advances to biological or biomedical applications, a development that 
attests to the increasing maturity of the technology.  
A challenge in using SRM for candidate-biomarker verification is the required 
sensitivity for the quantification of low-abundance proteins, given a dynamic 
concentration range of plasma proteins over 12 orders of magnitude  (Picotti P, 
2012). SRM has also been applied to study signalling pathways, for example, Wnt/β-
catenin signaling, a system of high biological and biomedical importance given its 
deregulation in different types of cancer. Similarly, SRM has been used to 
quantitatively monitor  linked to mammalian stem cell renewal and pluripotency in 
nuclear extracts from mouse embryonic stem cell (Hewel J. A., 2010). 
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2 SRM method 
 
2.1 Analytical approach 
 
Targeted metabolomics and proteomics focus on the quantitative 
measurements of a specific subset of known analytes representative of biologically 
relevant processes by  LC-MS/MS in Selected Reaction Monitoring scan mode. This 
approach was shown to be a valuable tool to identify altered pathways in 
pathological conditions and/or to define therapeutic modes of action . 
Aim of this project was the development of robust and versatile analytical procedures 
for the direct determination and quantification of proteins or metabolites in different 
biological samples.  
The methodological approach developed here are based on different steps: 1) 
identification of a set of proteins and metabolites of interest capable of satisfying a 
specific biological or clinic request 2) selection of transitions maximizing sensitivity 
and selectivity 3) optimization of SRM transitions by tuning acquisition parameters  
of the mass spectrometer 4) validation of the transitions in biological matrix to 
account to unspecific contributions of fragment ions background  5) quantification by 
SRM. 
 
2.1.1 Identification  of targeted analytes 
 
The first step of a targeted experiment is the selection of a set of compounds of 
interest. Depending on the sensitivity and accuracy required, hundreds and 
eventually up to 1000 analytes can be targeted in a single LC-MS analysis after the 
transitions have been optimized. The selection of the metabolites and proteins set 
might be on the basis of previous experiments or the scientific literature or in order to 
make possible  in vitro and in vivo studies for specific disease. 
In particular, for proteins analyses specific peptides (proteotypic peptides)  
(Bronstrup M. 2004).  that are unique for target protein and easily detectable by mass 
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spectrometry should be choosen.  The uniqueness of a peptide sequence in a 
proteome can be determined, in principle, from the genomic information, but the true 
complexity of proteomes is generally difficult to predict. The specific mass 
spectrometry signal response of different tryptic peptides from the same protein can 
differ by as much as 100-fold in intensity. The choice of peptides with favorable 
mass spectrometry properties is thus crucial, as it determines the sensitivity of the 
assay. Nowadays, information from prior experiments conducted on natural 
proteomes are available in different database as, for example, PeptideAtlas (Deutsch 
2008)3, the Global Proteome Machine Database (GPMDB) (Craig 2004)4, that can 
be used for identification of peptides that can be reproducibly detected and are thus 
likely associated with the most intense signals. Proteotypic peptides can be easily 
identified from this database, and peptides can be selected that best fit the objectives 
of a scoring experiment, such as the identification of proteins, splice forms, SNPs, 
post-translational modifications and more.  
Numerous software tools for evaluating the best SRM peptides have emerged such as 
Skyline  (MacLean B. 2010, Geiger T 1987). These software use different algorithms 
that consider sequence features and predicted physico-chemical properties of 
peptides to classify them as “proteotypic” that is, found in only a single known 
protein and therefore serves to identify that protein (Fig.2.1). 
 
Figure1 Definition of proteotypic peptides by using Skyline software  
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Among the parameters critical for predicting peptides were hydrophobicity, charge, 
energetic and structural properties. 
In general, short hydrophilic and long hydrophobic peptides should be avoided, 
whereas fully tryptic peptides with an average length of ~10 amino acids, devoid of 
residues prone to artifactual or post-translational modifications should be targeted.  
The introduction of artefactual chemical modifications due to sample processing is a 
potential source of error in quantitative MS experiments because a fraction of the 
targeted peptide might be converted into the modified form in an irreproducible and 
unpredictable manner and can bias the quantification. Therefore, care should be 
taken to avoid targeting peptides with a high propensity for artefactual modifications 
such as peptides containing methionine or tryptophan residues should be avoided, as 
the side chains of these amino acids are prone to oxidation, peptides containing 
glutamine or asparagine residues may be chemically unstable and convert to 
glutamate or aspartate. The rate of conversion is dependent on the surrounding 
sequence, for example, asparagine followed by glycine or proline is particularly 
prone to deamidation. In addition, N-terminal glutamine residues are quickly 
transformed to pyro-glutamate under acidic conditions(Geiger T. 1987). 
Similarly, peptide susceptible to undergo post-translational modifications, 
glycosylation, phosphorylation, etc. might to lead to bias as they can be present in 
various forms.  
 
2.1.2 Selection of optimal transitions 
 
 The combination of m/z  settings for the first and third quadrupole is 
referred as “transition”, it is important to select transition ions that maximize 
sensitivity and specificity of the SRM experiment. Several in silico methods  are 
available, and continue to be refined, which facilitate the choice of the transitions. 
During selection of suitable transitions for a targeted compound one selects the 
fragment ions for each precursor-ion charge state that provide the highest signal 
intensity and lowest level of interfering signals. Transitions can be selected from (1) 
libraries of previously collected MS/MS spectra in online repositories, (2) 
computational tools that predict fragmentation, (3) analysis of synthetic peptide 
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standards. Just as criteria for selecting target peptides exist, characteristic peptide 
fragmentations empirically found to provide a high signal intensity have been 
described. Several software tools, for facilitating transition selection have been 
described. Because SRM assays are largely conducted with triple quadrupole 
instruments, optimization has been directed to this type of mass analyzer. These 
employ fairly sophisticated algorithms to deliver putative SRM transitions based on a 
combination of theoretical rules and empirical observation for optimal peptide 
MS/MS. The current practice is to select two transitions for metabolites analysis (the 
most abundant for screening said quantifier and a second for confirmation as 
qualifier) and at least two to five most intense transitions per peptides for proteins to 
build an SRM assay. 
For metabolomics analysis, it has been used MassHunter Optimizer, part of the 
MassHunter Workstation, a commercial software package from Agilent for triple 
quadrupole LC-MS. It allows fast, sensitive compound identification and 
confirmation that helps design SRM acquisition. MassHunter also enables the 
optimization collision energy as well as select the best transitions from empirical 
data generated on the Agilent platforms using Optimizer-designed methods. 
For peptides and proteins analysis, it has been used Skyline, an open-source software 
platform that provides support not only for experimental design (selecting peptides 
and optimization of transitions) but also for downstream data analysis  (T. D. 
MacLean B. 2010).  
Skyline utilizes the ProteoWizard libraries  (Kessner D. 2008) to allow analysis of 
data from all MS instrument platforms, thus providing a vendor-neutral resource for 
sharing and creation of both methods and results across instrument platforms. 
Skyline facilitates the generation and refinement of proteomic peptide lists from 
protein sequences or database entries, both by utilizing online MS/MS spectral 
repositories and by supporting the generation of custom-built libraries based upon 
sets of locally acquired tandem spectral data. 
Skyline creates transition lists and vendor-specific instrument methods that can be 
imported directly into instrument control software for MS instruments from several 
vendors. Skyline also provides a platform for standardized analysis of SRM result 
files for peak integration and visualization and data quality assessment across 
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multiple analyses. Finally, Skyline allows the export of processed data in custom 
report formats compatible with subsequent statistical analyses, publication, and 
database deposition (Fig. 2.1). 
 
 
Figure 2.2: Skyline, definition of the transitions for a peptide: is the doubly charged 
precursor m/z , while the others are y-fragment m/z . The near window is the panel control to 
export transition list by optimizing the collision energy. 
However, there is a physical limit to the number of transitions that can be measured 
in the same analysis. The SRM cycle time is the product of the number of transitions 
recorded in the cycle and the time spent on acquiring each transition signal (dwell 
time). Monitoring too many transitions in an SRM run results in too long a cycle 
time and hence an insufficient number of data points to reconstruct the 
chromatographic elution profile of the targeted peptide, compromising accurate 
quantification . Alternatively, this results in a low dwell time and hence a reduced 
signal-to-noise ratio, compromising the detection of low-abundance components. 
This generates the well-known trade-off  between the number of transitions and the 
limit of detection of an SRM experiment  (Picotti P 2012). 
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2.1.3 Optimization of SRM transitions  
 
In order to increase the limit of detection and quantification of the SRM assays 
mass spectrometry parameters that  are molecule-dependent (such as declustering 
potential or cone voltage) or transition-dependent (for example, collision energy) 
optima. can be optimazed. To this end, instrument vendors often provide functions 
that linearly correlate collision energy or declustering potential with the precursor 
mass-to-charge ratio (m/z)  (MacLean B. 2010, Kuzyk 2009).  
In particular, ionization conditions have been optimized. Precursor charge state is 
essential for a sensitive detection. Charge states can be inferred from previous 
experiments on other ESI instruments. However, ionization devices and experimental 
conditions (flow rate, solvents, background) can influence charge state distributions. 
Moreover, during the ionization process, single ions need to be generated. The 
process of dissolvation and dissociation of ion clusters is supported by a voltage 
potential referred to as ‘declustering potential' (DP), ‘fragmentor voltage' or ‘ion 
transfer capillary offset voltage' depending on the manufacturer. At too high DP, 
compounds are fragmented already in the source. From plotting many experimentally 
determined DP optima, a positive linear correlation of precursor m/z value and DP 
optimum was determined (unpublished results). As the DP displays a broad 
optimum, individual optimization usually does not result in a significant signal 
increase. Individual transitions of a peptide have the same DP optimum if they are 
derived from the same precursor charge state. 
 During fragmentation singly charged y ions are the predominant type of fragments 
generated by CID in a linear collision cell. Only small b ions are usually observed. 
Fragments with m/z values close to the precursor should be avoided as such 
transitions are usually noisy. Fragments with m/z values above the precursor 
generally display the highest selectivity, as the singly charged chemical background 
cannot result in fragments with higher m/z than the precursor. In contrast, tryptic 
peptide ions are predominantly doubly or triply charged with one charge at each 
terminus. Upon fragmentation, one charge is lost and therefore a part of the 
fragments has an m/z value bigger than the precursor value. A parameter that is of 
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considerable importance is the collision energy, that is tuned to optimize the intensity 
of the fragment ions of interest: with increasing collision energy, a larger part of the 
precursor ions is fragmented and fragment ion intensity increases until this increase 
is overcompensated by the losses due to secondary fragmentation events. The 
optimal collision energy is approximately linearly correlated with the precursor mass 
for a given charge state. However, particular peptides or fragments deviate 
considerably from the predicted value. 
The easiest and most systematic way of optimizing ionization and fragmentation 
conditions is to test possible transitions in direct infusion mode and ramp the 
parameters . This process is partly automated by add-ons for the acquisition software.  
 
2.1.4 Validation of the transitions   
 
Transitions extracted for an SRM assay should be validated by addressing the 
likelihood that the chosen transitions and their intensity distribution are associated 
with the target peptide or metabolite. Each transition selected for a specific target 
should be evaluated in the context of the actual biological matrix to account for 
unspecific contributions of the fragment ions deriving from co-eluting species with 
similar properties. Typically, one measures 3–5 intense transitions for each 
endogenous peptide. When one applies an assay to a biological sample, the first 
question is whether it could be used to unambiguously identify the target peptide in a 
complex sample. 
Plasma is probably the most complex biological matrix, so it is important to evaluate 
the matrix effect that can affect the goodness of the analysis and the quality of the 
result obtained. Whilst this is readily achievable for low molecular weight markers, it 
provides a major challenge when looking for proteins or peptides. It has been 
estimated that human plasma contains proteins that span 10 orders of magnitude of 
concentration, and includes resident plasma proteins (high and medium abundance) 
and signaling proteins such as hormones and cytokines (low abundance). 
High abundance species comprise a small population of approximately 20 proteins, 
including albumin, haptoglobin, hemopexin and the immunoglobulins, which 
between them account for 99% of the total protein content.  
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Specifically, the matrix affects not only ion suppression, a major pitfall for the 
analyst, but also detection capability, repeatability and accuracy. 
The mechanism of the matrix effect in LC–MS, well described by Trufelli et al.2011, 
is not fully understood. One of the most important aspects is competition between an 
analyte and a co-eluting matrix component during ionization. As a result, there is a 
decrease in analyte ionization (ion suppression) or an increase in this ionization (ion 
enhancement). The matrix effect depends strongly on the type of ionization source. 
In ESI droplets are produced and a greater amount of additives (from eluents or 
sample matrices) may lower evaporation efficiency and the ability of analytes to 
reach the gas phase. 
Reactions in the electrospray source depend on the properties of solvents and 
additives (like volatility, viscosity, pH or electrolyte concentration), the 
physicochemical properties of analytes (pKa, hydrophobicity, proton affinity or ion 
solvation energy) and the operating parameters of LC–MS instruments (flow rate, 
temperature and voltage). Hence, all these variables make ionization a highly 
complex and changeable process. Furthermore, co-eluting components may produce 
similar ions in MS or MS/MS experiments, which leads to the erroneous 
interpretation of results, especially when these components are present at high 
concentrations in the extract and eluted in the same retention window as the target 
compounds. 
In summary, the consequence of the matrix effect is primarily a reduction or increase 
in the detector signal of the analyte; there may also be problems with repeatability, 
ion ratio (modification of typical fragmentation patterns, and hence difficulties with 
database searching), linearity and quantification (false negative diagnostics or 
overestimation of analyte concentration) (Trufelli H. 2011). 
Several strategies have been put forward to eliminate the problems resulting from 
matrix  (Frenich A.G. 2009, Kostiainen R. 2009). The most effective of them is 
exhaustive sample clean-up   used immunoaffinity depletion of highly abundant 
plasma proteins in combination  with peptide fractionation by strong- or mixed-mode 
cation exchange chromatography, which can help to remove interferents, and 
improves the LOQs to 1–10 ng ml− but it does run the risk of analyte loss. The 
second strategy is to improve chromatographic separation. This allows the analytes 
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to be eluted in an appropriate period of time, in order to avoid co-elution with matrix 
components. A third approach is to dilute the final extract several times so that fewer 
matrix components will be injected into the analytical system 
The matrix effect can be compensated for with appropriate calibration methods, 
firstly, by using calibration standards in pure solvents, and secondly, by using 
standards in the matrix (Frenich A.G. 2009).  
Finally, the standard-addition method is a much cheaper and useful approach when 
no blank matrix is available for the calibration. Here, a known amount of analyte 
(spike) is introduced into aliquots of sample extracts containing the target compound, 
so that any co-extracted impurity is accounted for in the calibration; one has to bear 
in mind, however, that the volume of standard added must be small enough to 
prevent sample extract dilution. By using this methodology, the unknown 
concentration initially present in the sample can be calculated by extrapolation. 
 At this point, for each analyte the recovery value (%) was estimated by measuring 
the concentration of analyte added to real samples (spiked samples). 
 
 
where is that: 
C1: analyte concentration measured after the addition  
C2: analyte concentration measured before the addition 
C3: added concentration 
 
2.1.5 Quantification by SRM 
 
SRM-based quantification can be coupled to different strategies for relative or 
absolute protein quantification. 
The aim of relative quantification is to express the amount of a targeted compound in 
one state or sample relative to that of a second state or sample. Approaches to 
relative quantification that can be coupled to SRM include label-free or stable 
isotope–labeling methods. Isotope-labeling methods introduce stable isotope tags to 
proteins or peptides and rely on the concomitant mass spectrometry measurement of 
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heavy and light or differently labeled peptides as an internal standardization, thus 
correcting for experimental and instrumental variability, downstream of the label-
mixing step (Picotti P 2012). Label-free approaches  (Rinner O. 2007)) rely on the 
direct evaluation of mass spectrometry signal intensities of naturally occurring 
peptides contained in a sample. Although in principle each of these quantification 
methods can be coupled to SRM analysis to be noted that methods based on 
chemically added tags normally change peptide-fragmentation patterns as well as the 
precursor-ion mass. In such cases, new SRM assays should be developed that are 
specific for the labeled peptides. In contrast, labels that conserve the chemical 
structure of peptides, such as metabolic labeling, also conserve their fragmentation 
patterns and thus the relative transition signal intensities. One can thus easily derive 
the assays for the heavy form of a peptide from the fragment-ion spectrum of the 
light peptide and the knowledge of the site and type of incorporation of the heavy 
label. A drawback of label-based methods is the introduction of additional sample-
processing steps. An intermediate solution between the high precision of label-based 
approaches and the simplicity of label-free methods is the use of a single labeled 
peptide as a reference standard for all other measured endogenous peptides (Zhang 
2011). 
The gold standard for absolute quantification is stable-isotope dilution. The most 
commonly used approach relies on isotopically labeled reference peptides that are 
chemically identical to the light native peptides (AQUA peptides)  (Gerber 2003). 
The analytical precision of this method is high and can result in up to 5% errors in 
the estimation of the amount of peptide originally loaded onto the liquid 
chromaography system. However, issues such as incomplete digestion of the target 
protein, partial artifactual modification of the target peptide or partial loss of the 
synthetic peptide before addition can affect the accuracy of this approach. For such 
reasons, the absolute quantification method is sometimes referred to as 'precise 
relative quantification  (Picotti P 2012).  
In our SRM experiment, quantification was carried out by the external standard 
method  with the realization of calibration curves, considering that areas subtended to 
peaks, for each transition, are proportional to concentration. The area under this 
curve is the extracted ion current (XIC) of a specific transition. XICs of peptides of 
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interest are extracted from the original data file. Filters are used to correct baselines 
or to remove artefactual spikes. XICs are then smoothed with an average filter before 
performing a closing and an opening mathematical morphology operation with a 
small flat structuring element. The closing operation eliminates thin valleys and 
conserves the intensity of local maxima, while the opening operation eliminates thin 
peaks (i.e. remaining spikes) and conserves the intensity of local minima. Hence, 
detection of peak positions is performed on the closed profile, and the opened profile 
is used to eliminate remaining spikes. The peak boundaries are searched on the 
closed profile, and the peak area (i.e. the quantification value) is computed. 
Another important and critical procedure in protein quantification is data 
normalization. Linearity determines the highest measurable concentration within the 
specified conditions. The lower limit of detection (LLOD, often referred to as LOD) 
and the LOQ are defined, respectively, as the concentration level at which the analyte 
can be reliably detected in the sample under consideration and as the level at which 
the analyte can be detected and measured with sufficient precision. Several methods 
are used to determine LOD and LOQ (Armbruster D. A. 1994) (Zorn M. E. 1997). 
The simplest one consists in calculating LOD and LOQ for a given analyte as the 
amount of this analyte providing a signal corresponding to the mean value of 
repeated blank sample measurements +3 and +10 standard deviations, respectively. 
These strategies are simple and cost-effective and have demonstrated high 
reproducibility and linearity. 
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3 Metabolomics and Xenobiotics 
 
3.1 Introduction 
 
In recent years, metabolomics has been widely used in toxicology, mainly 
because it has the ability to provide information to better understand the mechanisms 
of toxicity, while also providing the ability to identify biomarkers. 
In this context, metabolomics become a valuable tool for toxicology. Like the other 
"omics" sciences, metabolomics uses high-throughput performance analysis and the 
information that it provides are closer to the phenotype and therefore more easily 
referable to the classic toxicological endpoint. The metabolomic analysis may be 
performed on biological fluids, as well as on tissues and cellular cultures; unlike 
traditional histopathological methods, it requires small volume of sample, allowing a 
non-invasive sampling, constitute an important advantage for toxicological studies 
that are based on the use of small rodents as animal models (Ebbels ,2007). 
Moreover , the low cost allows a greater number of replicas and evaluations of 
concentrations at different time for monitoring of physiological states up to overt 
stages of intoxication (Craig , 2006; Schnackenberg et al., 2009). 
Exposure to chemicals (xenobiotics) by feeding, environment or drugs is almost 
inevitable for all living beings, including humans. Interactions between xenobiotics 
and biological systems are bi-directional; in fact although the xenobiotics can be 
processed by the biological system through absorption, dislocation, metabolism and 
excretion, the entire biological system, or part of it, it may be severely compromised, 
particularly when subjected to high doses or repeated exposures.  
The metabolic activities, which include both the xenobiotic to endogenous 
metabolism, play a central role in the damage caused by exposure to xenobiotics, 
especially for xenobiotics that induce toxicity (XIT); numerous toxicological studies 
have shown that the formation of reactive metabolites and disruption of endogenous 
metabolites, constitute the key events of the beginning and progression of toxicity 
caused by the XIT (Nicholson, 2002). Chemical and biochemical analysis of genes, 
45 
 
proteins, and metabolites are commonly conducted for acquiring information on 
toxic activity of any XIT in order to understand the mechanisms of toxicity that 
involve changes at the gene, protein and metabolic level, respectively. However, 
while changes at the gene and protein level, reflecting potential physiological 
changes, alterations of the metabolome are directly related to the real consequences 
of exposure to toxic xenobiotics; this is due to the fact that metabolites are the end 
products of biological processes. Therefore the study of the metabolome, resulting 
from exposure to XIT, is fundamental to understanding the mechanisms that regulate 
the toxicity. 
“Endocrine Disrupting Chemicals" (EDC), constitute a special class of xenobiotics 
that can alter the normal hormonal homeostasis. According to the definition adopted 
by the European Union "an interferent endocrine is an exogenous substance or a 
mixture , that alters the endocrine system function, causing adverse effects on the 
health of an organism, or its progeny, or (sub) population”. The assessment of risks 
associated with exposure to EDCs concerns various areas, as this class of 
compounds, characterized by high chemical and physical heterogeneity, including 
environmental contaminants, herbicides, pesticides and compounds commonly used 
in industrial manufacturing, including food grade (De Coster, 2012) 
The thyroid, endocrine gland strongly influenced by the external environment, is the 
target of a large number of these interfering, currently classified as Thyroid-
Disrupting Chemicals (TDC) (Crofton, 2005). Among these, ethylene bis-
dithiocarbamate fungicides, of which ethylene thiourea (ETU) is the major 
metabolite, and organophosphorus pesticides,  chlorpyrifos (CPF) are widely used in 
agriculture for the poor tendency to bio-accumulation. The massive use of these 
substances has clearly led to higher exposure often unconscious, not to high doses for 
several organisms, including humans (Nicholson 1999). 
Although the thyroid alteration linked to Etu and CPF exposure at has been studied 
both in vivo models massively exposed as well as in workers exposed to high 
amounts (Bouhifd 2013), in both cases it was found reduced serum levels of thyroid 
hormones T3 and T4 (Watkins 2002). Recently it has been shown that chronic 
exposure, even at low doses, is associated with hormonal and homeostatic alterations 
in sex hormones, with possible impact on male and female fertility. 
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The research activity, in collaboration with Prof. De Felice and prof. Concetta 
Ambrosino at Biogem , Ariano Irpino (AV), have been focused on some hormone of 
hypothalamic-pituitary-thyroid axis and two TDC  which alter the endocrine activity, 
in order to assess the direct effects of exposure to pesticides in humans through the 
use of model organisms.  
 
 
3.2 Material and methods 
 
3.2.1 Chemicals and reagents 
 
Triiodothyronine (T3), thyroxine (T4), 17β-estradiol (17βe), testosterone (T), 
chlorpyrifos (CPF) and ethylenethiourea (ETU) were purchased from Sigma-Aldrich. 
All the solutions and solvents were of the highest available purity and were suitable 
for LC–MS analysis and purchased from J. T. Baker (Phillipsburg, NJ). All stock 
solutions were stored at −20 °C.  
 
3.2.2 Preparation of standard solutions 
 
Standard solutions were prepared by dissolving the equivalent of 1 mg of the 
respective metabolites in 1mL of methanol. Testosterone standard solution of 1000 
ng\uL was dissolved in a solution of dichloromethane and acetonitrile (9:1). 
A standard solution of 500 pg\uL of each metabolite was used for optimization of the 
SRM transition. Standard solutions at different concentrations were prepared by 
serious dilution and were used for calibration curves. Standard mixtures for each 
analyte were prepared as follows: 0.5, 1,0, 5, 10, 25, 50, 100  pg/μl for T3, T4, ETU; 
1, 5, 10, 25, 50, 100, pg/μl for CPF and 17β-estradiol; 5, 10, 25, 50, 100, 150 for T. 
All standards were kept at -20ºC before LC MS/MS analysis. 
 
3.2.3 Spike and sample preparation 
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In order to validate the optimized method, serum samples were spiked, prior to the 
extraction, with appropriate concentrations of the standard mixture of target analytes. 
Finally, for each of 155 samples of mouse serum, an aliquot of 100 µl was treated 
with 300 µl of cold ethanol. The mixtures were stored at -20°C for about 30 minutes 
followed by centrifugation at 10000 rpm for 10 min at room temperature. The clear 
supernatant, subsequently subjected to analysis, was transferred to a 1.5-mL tube and 
stored at -20°C. 1 ul of supernatant was used for analysis. 
 
 
3.2.4 LC–MS/MS instrumentation and condition 
 
SRM analysis was performed using a Agilent 1200 series LC coupled to a 
6420 triple quadrupole MS. Analytes were separated on a Phenomenex Kinetex 
reverse-phase C-18 column (100mm x 2, 1 mm; 5 µm, 100 Å) at a flow rate of 200 
L/min with a 5% to 95% linear gradient in 12 min (A solvent 0.1% formic acid, 2% 
ACN in water; B solvent 0.1% formic acid, 5% water in ACN).  
For each compound, data acquisition parameters for SRM in positive ion mode, were 
automatically optimized by MassHunter Optimizer software, using a standard 
solution of 500ng\ml (500ppb) Based on the analytical parameters optimized in the 
previous stage, the acquisition methods were processed through software 
MassHunter Data Acquisition.  
 
3.2.5 Data Processing 
 
Extracted mass chromatogram peaks of metabolites were integrated using Agilent 
MassHunter Quantitative Analysis software (B.05.00). Peak areas of corresponding 
metabolites are then used, as quantitative measurements, for assay performance 
assessments such as assay variation, linearity etc. 
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3.3  Results  
3.3.1  Mass spectrometer parameters optimization 
 
The setup of the SRM analytical method has required the identification of the 
specific acquisition parameters for each molecules For this purpose, standard 
solutions 500 ng \ ml of each analyte were introduced for DI (direct injection), and 
analyzed by the Mass Hunter Optimizer software. The optimization has proceeded by 
a suitable definition of the following parameters: 
- Molecular weight of the analyte 
- Polarity of ionization 
- Minimum m / z ratio detectable for product ions  "low mass cut-off" 
- Collision energy (CE) 
- Fragmentor Voltage. 
 
The low mass cut-off refers to the m / z value below with ions has unstable 
trajectories and for this reason is excluded from fragmentation.  
The optimization of collision energy and fragmentor values guarantees for each 
analyte the best result in terms of signal intensity. Finally, for each analyte the two 
product ion with the major abundance are selected.  
The transition corresponding to the highest signal has defined as quantifier, useful for 
quantification.  However, by acquiring additional signal corresponding to the next 
highest product ion (qualifier), enough information may be considered available for 
confirmation, particularly if the ratio of signal between the two product ions is 
consistent between the calibration standards and the unknown samples. 
Based on the analytical parameters optimized, a SRM methods has been developed 
using the software MassHunter Data Acquisition, It includes transitions, specific 
parameters related to the ionization and fragmentation of each analyte and the dwell 
time that indicates time spent to monitor single transition. The results are showed in 
the table 3.1. 
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Compound 
Name 
Precursor 
Ion m/z 
Product 
Ion m/z 
Dwell 
(ms) 
Fragmentor  
(V) 
Collision 
Energy            
(V) 
Polarity 
Thyroxine (T4) 777,9 
731,6 200 
135 
28 
Positiva 
322,8 200 92 
Triiodothyronine 
(T3) 
651,9 
605,7 200 
135 
20 
Positiva 
197,1 200 84 
Testosteron 289,4 
108,9 200 
135 
24 
Positiva 
97,1 200 20 
17βEstradiol 255,4 
144,1 200 
135 
44 
Positiva 
115,1 200 72 
Ethilenthiourea 103,5 
60,1 200 
135 
8 
Positiva 
44,1 200 8 
Chlorpiriphos 350,5 
199,1 200 
135 
16 
Positiva 
108,9 200 76 
 
Table. 3.1  Precursor ion, product ions and mass spectral parameters optimized for 
all analytes. 
 
 
3.3.2 Quantification and normalization  
 
1 ul of a mixture of targeted metabolites standard solution at different 
concentrations were separated in a single run by a LC-system.  The total ion current 
(TIC) chromatogram as a function of retention time was registered from detector, 
showing a good peak shape for each analyte. 
Identification and quantification is based on extracted ion chromatogram (XIC) 
signals of different transitions (Fig 3.1). 
50 
 
 
 
Figure 3.1- Extracted ion chromatogram (XIC) chromatogram for a standard mixture 
solution of six metabolites (T3, T4, CPF; ETU; T; 17β). 
 
The calibration curves were obtained by analyzing standard solutions at different 
concentrations. Good linearity (R
2
 > 0.99) is obtained for all compounds over two 
orders magnitude in concentration range (Fig 3.2). 
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Figure 3.2 : Standard calibration curves obtained for the six analytes. 
 
Limit of detection (LOD) and limit of quantification (LOQ) were determined as the 
lowest spiked concentration of each compound which, upon addition to the serum, 
was experimentally determined with acceptable precision (better than 10%) and 
accuracy (100 ± 20%). The matrix effect and relative recovery was determined 
interpolating from respective calibration curve the value “abundance” obtained by 
spike analysis of each analyte (Tab.3.2).  
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Compound Name 
Linear 
range 
(pg/ul) 
Recovery 
% 
LOD 
(pg/ul) 
LOQ 
(pg/ul) 
Thyroxine (T4) 0,5-100 
      
90 0,34 1,02 
      
Triiodothyronine 
(T3) 
0,5-100 
      
85 0,27 0,80 
      
Testosteron 5-150 
89 2,58 7,81 
      
17βEstradiol 1-100 
      
88 1,99 6,04 
      
Ethilenthiourea 0,5-100 75 0,53 1,61 
Chlorpiriphos 1-100 80 0,92 2,78 
 
Table 3.2 Normalization parameters for all compounds. 
 
3.3.3 Validation of the method 
 
According to the conditions of the method developed during optimization step, 
155 murine serum samples from model organisms, felt with different quantitative of 
the two pesticides via food and water, were subjected to quantitative analysis. Target 
analytes were extracted from murine serum by protein precipitation prior to LC-
MS/MS analysis. Quantification was achieved by the external standard method by 
interpolation on calibration lines using Agilent MassHunter Quantitative Analysis 
software (B.05.00). 
The results which take into account the recovery values for each analyte and are 
summarized in the table 3.3.  
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Analyte 
♀ Concentration 
range (pg/µL) in 
74 samples (*) 
♂ Concentration 
range (pg/µL) in 81 
samples (*) 
Testosterone 8,32 - 53,34 47,90 - 159,99 
Estradiol 6,49 - 173,44 6,06 - 81,50 
Triiodothyronine 0,87 - 18,27 0,94 - 4,60 
Thyroxine  14,88 - 74,60 17,58 - 101,32 
Chlorpyrifos 2,98 - 11,54 3,17 - 12,31 
Ethylenethiourea 1,96 - 255,26 1,87 - 1028,82 
   
 
Table 3.3. Murine serum concentratio ranges determined for both male and 
female. 
 
3.4 Discussion 
 
Mass spectrometry-based metabolomics is a valuable tool for the study of 
various biological processes and is highly diffused in many scientific fields, 
including the toxicological, for its efficiency and reliability. 
The mass spectrometry applied to targeted metabolomics has been shown a number 
of important advantages respect to classical method as immunoassays that are 
typically used for quantitative analysis,. In fact, the proposed analytical methods 
have allowed to the simultaneous and high sensitivity quantification, of specific 
molecules in complex mixtures. The SRM mode have a strong selective nature that 
can significantly reduce the risk of false positives. In addition, the reduced required 
volume (100ul for extraction), associated to a relatively non-invasive sampling, 
demonstrate the absolute compatibility with the toxicological in vivo studies, limiting 
the sacrifice of the animal models. The high analytical productivity, combined with a 
wide versatility of the techniques developed, had led to the evaluation of several 
samples and monitoring of treatments and physiological states emphasizing the 
effects of these pesticides on hormonal activity and fertility. 
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4 H2S SULFUR METABOLITES  
 
4.1 Introduction 
 
H2S is an important biological signalling molecule involved in vascular and nervous 
system functions, whose biogenesis and regulation are still poorly understood. 
Excessive H2S production in hyperhomocysteinemia may contribute to the associated 
cardiovascular pathology  (Chiku T, 2009). However, despite the growing interest in 
H2S biology and the therapeutic potential of H2S-releasing compounds (Kashfia K., 
2013), surprisingly little is known about the enzymatic production of this gas and 
how it may be influenced by changes in sulfur amino acid levels in disease states 
(Fig. 4.1).  
 
 
Figure 4.1 Cystathionine cleavage and H2S-generating reactions 
 
Several studies demonstrated that H2S  occurrence can be inferred by a novel 
biomarker, homolanthionine, which has been reported in urine of homocystinuric 
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patients, and by lanthionine generated by condensation reaction of two molecules of 
cysteine (Chiku T, 2009) . 
 It has been shown that early detection and/or pharmacological treatment can prevent 
many clinical complications associated with these diseases and can substantially 
improve the quality of life of patients. The determination of  these molecules require 
screening methods  with an high degree of  specificity and sensitivity, avoiding  high 
cost and lengthy analysis.. Currently, there is increasing interest in developing 
accurate methods for the quantitative analysis of metabolites in biological samples. 
Liquid chromatography-tandem mass spectrometry (LC-MSMS ) methods have been 
successfully used in screening protocols to identify and determinate a wide range of 
metabolites in different matrices, as well as to study their metabolisms (Dettmer K., 
2007; Kitteringhama N. R., 2009). Nowadays, automatic rapid high performance 
liquid chromatography (HPLC) tandem mass spectrometry has become the technique 
of choice for several metabolite analysis thanks to the capacity to simultaneously 
separate and determinate multi component mixtures. Modern multiplex instruments 
can analyze thousands of samples per month so that, the generally high instrumental 
costs, the cost of the individual assay is affordable (Gosetti F., 2013). In addition, the 
improved specificity and resolution offered by triple quadrupole mass spectrometry 
allow their application in profiling (namely identification and determination) of 
metabolites in human biological matrices. The selectivity is achieved by the selected 
reaction monitoring  characteristic of triple quadrupole mass spec instrument.  
A number of methods for measuring cystathionine and homocysteine have been 
reported (Bártl J, 2014), although no analysis of H2S diagnostic metabolites has yet 
been published. 
Here, a method utilizing liquid chromatography-electrospray tandem mass 
spectrometry (LC-MS/MS) in multiple reaction monitoring ion mode has been 
developed and evaluated for the determination of keys H2S metabolites  in plasma, 
in collaboration with First Division of Nephrology, Department of Cardio-thoracic 
and Respiratory Sciences, Second University of Naples. The simultaneous,  sensitive, 
fast, and reproducible measurement of homocysteine,  homolanthionine, homoserine, 
lanthionine, and cystathionine concentrations might be useful in the highlighting the 
mechanism responsible for hyperhomo-cysteinaemia. 
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4.2 Materials and methods 
 
4.2.1 Chemicals and reagents 
 
Homocysteine,  homoserine, lanthionine, and cystathionine were purchased from 
Sigma-Aldrich. All the solutions and solvents were of the highest available purity 
and were suitable for LC–MS analysis. All stock solutions were stored at −20 °C. 
 
4.2.2 Preparation of  standards solutions 
 
Standard solutions were prepared at 1 mg/mL concentration in 50:50 
methanol/water with 0.1% formic acid. A stock solution of 500 pg\uL of each 
metabolite was used for optimization of the SRM transition. 
Standard solutions at different concentrations were prepared by serious dilution and 
were used for calibration curves. All standards were kept at -20ºC before LC MS/MS 
analysis. 
 
4.2.3 Spiked and samples preparation 
 
To prepare spikes, blood samples from healthy anonymous donors without any 
hematological diseases were collected in EDTA tubes and enriched with different 
amount of lanthionine. These spiked blood samples were stored at −20 °C until the 
analysis. 
A 200  μL  of plasma sample was submitted to protein precipitation with 600 ul di 
Ethanol and vortexed thoroughly. The mixture was stored to – 20°C for about 30 
minutes to complete protein precipitation. After centrifuged at 13,000×g for 10 
minutes, the supernatant  was then directly transferred into HPLC auto sampler and 5 
μl  analyzed using LC–MS/MS. 
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4.2.4 LC–MS/MS instrumentation and conditions 
 
The LC–MS/MS analyses were carried out  by using a 6420 triple Q system with 
a HPLC 1100 series binary pump (Agilent, Waldbronn, Germany). The 
chromatographic separation was achieved on reverse-phase C-18 column (Kinetex -
Phenomenex 100mm x 2,1 mm; 5 µm, 100 Å)  with eluent A (0.1% formic acid, 2% 
MeOH in water) and eluent B (methanol) and the flow rate was 0.200 mL/min. 
Starting condition was 5% to 95% A in 8 minutes than to 100% for 2 minutes. 
Tandem mass spectrometry was performed using a turbo ion spray source operated in 
positive mode, and the selected reaction monitoring (SRM) mode was used for the 
specific analytes.   
 
4.2.5 Data processing  
 
The ideal conditions for transitions detection were determinated via Agilent 
MassHunter Optimizer software. Extracted mass chromatogram peaks of metabolites 
were integrated using Agilent MassHunter Quantitative Analysis software (B.05.00).  
 
 
4.3 Results  
 
4.3.1 Mass spectrometer parameters optimization 
 
The transitions for each metabolite were properly selected by MassHunter 
Optimizer software in post-column infusion experiments by directly infusing 
analytes  dissolved in the mobile phase. A SRM methods has been developed using 
the software MassHunter Data Acquisition and all analytical parameters optimized 
are showed in the table 4.1. 
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Compound Name 
Precursor 
Ion m/z 
Product 
Ion m/z 
Fragmentor  
(V) 
Collision 
Energy            
(V) 
Polarity 
Cystathionine 223,3 134,1 81 5 Positive 
  223,3 88 81 25 Positive 
Lanthionine 209,3 120 81 9 Positive 
  209,3 74 81 25 Positive 
Homocysteine 136,2 90 81 5 Positive 
  136,2 56,1 81 17 Positive 
Homoserine 120,1 74 81 5 Positive 
  120,1 56,1 81 17 Positive 
Homolanthionine 237,1 148 81 5 Positive 
  237,1 102 81 30 Positive 
 
Table 4.1 Precursor ion, product ions and mass spectral parameters optimized for all 
analytes. 
 
4.3.1 Quantification and normalization 
 
 
Calibration curves were obtained by external standard method by plotting peak 
areas against concentration (pg/μl), and linear functions were applied to the 
calibration curves. Data were integrated by Mass Hunter quantitative software 
showing a linear trend in the calibration range for all molecules (Fig 4.2). 
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Figure 4.2 : Standard calibration curves obtained for the five analytes. 
 
The limits of detection (LODs) were determined by evaluating the noise signal in 
plasma and employing a signal-to-noise ratio of 3:1. The lower limits of 
quantification (LLOQs) were determined as the lowest spiked concentration of each 
analyte which, upon addition to the blood sample, was determined. Recovery was 
calculated by comparing the extraction yield before and after the standard addition of 
the different analytes into the control blood samples The results of LOD, LLOQ and 
recovery are reported in Table 4.2. 
Compound 
Name 
Calibration 
range 
(pg/μl) 
Recovery 
% 
LOD 
(pg/ul) 
Limit of 
detection 
LOQ (pg/ul) 
Limit of 
quantification 
Cystathionine 0,5-150 90 0,54 1,62 
Lanthionine 0,5-150 94 0,38 1,15 
Homocysteine 0,5-150 92 0,31 0,93 
Homoserine 0,5-150 91 0,14 0,43 
Homolanthionine 0,5-150 94 0,42 1,07 
 
Table 4.2 Normalization parameters for all compounds. 
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4.3.1 Validation of the method 
 
To evaluate the applicability of this method, a control group of 22 healthy subjects 
and 67 uremic subjects on chronic hemodialysis were analyzed: plasma sample was 
submitted to protein precipitation and the supernatant  was then directly analysed in a 
LC-MS/MS assay.  
 
 
Figure 4.2  XIC chromatograms of all targeted analytes in a serum sample. 
 
The concentrations were calculated by integration on calibration curves using 
Agilent MassHunter Quantitative Analysis software (B.05.00) Table 4.3.  
Metabolites ctr patients 
Cystathionine (pg/μL) 148,4 1096,1 
Homoserine (pg/μL) 330,7 637,4 
Lanthionine (pg/μL) - 64,8 
Homolanthionine (pg/μL) 70,5 112,2 
Omocysteine 92,7 177,5 
 
Table 4.3 Sulfur metabolites levels in healthy subjects and uremic subjects (mean 
value). 
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The experiments were performed in duplicate and averaged. To evaluate the 
applicability of this method to routine clinical practice, we evaluated the stability of 
the metabolites of interest in serum  over a 2-week period, which represents sufficient 
time for transporting a sample from the patient to the laboratory. The stability was 
tested by analyzing serum samples spiked with target molecules at final  
concentrations of 50 pg/ul.  All the samples were stored at -20°C, and the SRM 
analyses showed a decreases in concentrations of  about 10 % after 14 days of 
storage. Because these decreases in the analyte concentrations were lower than the 
inter-assay variability, they did not appear to be significant. 
 
 
4.4 Discussion 
 
A simple and rapid method for the simultaneous measurement of five 
clinically relevant sulfur metabolites in plasma has been set up. The analytical 
performance of our method, i.e., its linearity, recovery and reproducibility, is 
analogous to the performance previously described in other studies based on the 
detection of metabolites in plasma matrix, indicating the suitability of our method for 
routine use (Perna A. F., manuscript submitted). The novelty of our method  based 
on targeted mass spectrometry in multiple reaction monitoring ion mode, lies in the 
determination of two important markers of the H2S pathway, lanthionine and 
homolanthionine while simultaneously analyzing homocysteine, homoserine, and 
cystathionine. The diagnostic utility of this method is concerned its application at 
clinical samples as a rapid screening procedure for detecting patients with severe  
hyperhomocysteinemia.  
Low reagent costs together with the relative simplicity of sample preparation make 
the LC-MS/MS method well suited, not only for research work but also in those 
laboratories with a tandem mass spectrometer, for the measurement of routine 
clinical samples. Once set up, this SRM method was successfully applied as a rapid 
screening procedure for detecting patients with severe hyperhomocysteinemia (Perna 
A. F., Manuscript submitted).  
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5 Oxylipins 
5.1 Introduction    
 
Recently, a new class of oxygenated fatty acid metabolites, previously strongly 
studied in mammals and higher plants, was also found in marine diatoms, amongst 
the most abundant forms of photosynthetic plankton in the ocean (d’Ippolito et al., 
2005, Fontana et al., 2007) and referred to as oxylipins (Fig.5.1), oxidized 
compounds formed from fatty acids by a reaction involving at least one step of 
mono- or dioxygenase-dependent oxidation (Gerwick et al., 1991). 
 
 
Figure 5.1 Oxylipins from lysed diatom cells. 
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The presence of a series of these products ranging from 16 to 20 carbon atoms were 
reported (d’Ippolito et al.,2005). Oxylipins have been recognized as important 
chemical mediators in ecological and physiological processes of marine and 
freshwater diatoms leading to the production of a great multiplicity of  species, such 
as hydroperoxy-hydroxy-, keto-, oxo-acids,epoxy alcohols and aldehydes 
(Wendel&Jüttner, 1996; Pohnert& Boland, 2002; Wichard et al., 2005a; d’Ippolito et 
al., 2005). 
Oxylipin analysis is a powerful but under-utilized approach, which may give 
important information on the cell physiology. In plants, animals and fungi the 
sequence of lipoxygenase pathway leading to the oxylipins formation shows striking 
similarities and evidence on their role in the pathological and physiological processes 
in these organisms was accumulated in the last decades. Thus the presence of the 
complex network of oxygenated products in marine diatoms opens intriguing 
questions about the role of fatty acid derivatives for example in the regulation of 
phytoplankton communities. 
Oxylipin distribution is relatively wide within different diatoms and these 
compounds characterize an evident species-dependent specificity of the metabolic 
signature that arises from the variability of both the fatty acids recognized as 
lipoxygenase (LOX) substrates and the enzymatic activities downstream of the LOX 
processing (d’Ippolito et al., 2005). Methods generally used for their analysis are all 
based on GC/MS and take advantage of the two basic types of detection: electron 
ionization and chemical ionization. However, GC is not the best analytical method 
for all oxylipins as some, although stable in the fridge, degrade or rearrange when 
analysed at high temperatures, causing losses and/or the artifactual generation of 
other oxylipins. However, compounds such as fatty acid (FA) hydroperoxides and 
some other low-stability oxylipins are often better analysed by liquid 
chromatography (LC). In addition, many large or polar oxylipins (e.g. oxylipin 
glycosides) are difficult to fractionate with GC and are better separated by LC 
(Schmelz et al. 2003; Muller 2006). 
A method utilizing liquid chromatography-electrospray tandem mass spectrometry 
(LC-MS/MS) in selected reaction monitoring in positive ion mode has been 
developed and for the first time, the developed SRM method was applied to the 
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determination of oxylipins pattern in extracts of marine diatoms Skeletonema 
marinoi from laboratory cultures (Pane F. et al, manuscript submitted) . 
The research activity was developed in collaboration with Dr. Adrianna Ianora and 
Dr. Giovanna Romano from the Zoological Station ' A. Dohrn ' Naples. 
 
5.2 Material and methods 
 
5.2.1 Chemicals and reagents 
 
5-HEPE (5-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid) and 15-
HEPE ((15R)-15-hydroxyeicosa-5Z,8Z,11Z,13E,17Z-pentaenoic acid were 
purchased from Sigma-Aldrich. All the solutions and solvents were of the highest 
available purity and were suitable for LC–MS analysis and purchased from J. T. 
Baker (Phillipsburg, NJ. All standards and solutions were stored at −20°C. 
5.2.2 Preparation of Standard solutions 
 
The stock solutions were prepared by adding 1.00 mL aliquots of each analyte 
to a 10-mL volumetric flask and bringing the standard to volume with 20/80 
methanol/water (v/v) to yield a standard solution with 1000 μg/mL of each analyte. 
The stock solutions were stored at −20 C until the analysis. Final 2 μg/mL individual 
analyte standard solutions were prepared, by serial dilution from stock solutions, and 
were used for mass spectrometric tuning and for calibration curves. Standard 
mixtures for each analyte were prepared as follows: 5.0, 25.0, 50.0, 125.0, 250.0 
pg/ul for each analyte.  All standards were kept at -20ºC before LC MS/MS analysis. 
 
5.2.3 Cell culturing and experimental conditions 
 
Batch cultures of Skeletonema marinoi (CCMP 2092) were grown in silicate-
enriched Guillard's f/2 medium (Guillard, 1975) prepared with 0.2-µm-filtered and 
autoclaved seawater collected in the gulf of Naples. Cultures were growth in two-
litre polycarbonate bottles constantly bubbled with air filtered through 0.2 µm 
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membrane filters (Sartorius, Goettingen, Germany). Cultures were kept in a climate 
chamber (RefCon, Napoli, Italy) at 20°C on a 12 h : 12 h light: dark cycle at 100 
µmol photons m
-2
 s
-1
.Cells were harvested at the stationary phase by centrifugation at 
3,900 g for 30 minutes at 4°C using a refrigerated centrifuge with a swing-out rotor 
(DR 15P, Braun Biotechnology International, Allentown, PA, USA). Samples were 
frozen in liquid nitrogen and kept at -80°C until analysis. 
 
5.2.4 Spiked and samples preparation 
 
A cell pellet (about 5 g wet weight) was suspended in distilled water (1 ml/g of 
wet pellet), sonicated for 1 min at 4° C and left at room temperature in order to allow 
wound induced reactions to take place. After 30 min, acetone in equal volume with 
water was added.  The standards,  5HEPE and 15-HEPE (30 μg/g of pellet) was 
added to a saline buffer used as control matrix, to correct the recoveries of the 
analytes. The resulting suspension was centrifuged at 2000 g for 5 min at 5° C and 
successively extracted with dichloromethane (equal volume with aqueous phase). 
Using a Pasteur pipette, the upper organic layer was transferred into a centrifuge 
tube. 0.2 ml of upper organic layer was filtered through a 0.2-μm PTFE syringe filter 
(Pall Acrodisc 13mm) into an LC vial for analysis. 
  
 
5.2.5 LC–MS/MS instrumentation and conditions 
 
1 μl of supernantant were analysed by using a 6420 triple Q system with a HPLC 
1100 series binary pump (Agilent, Waldbronn, Germany). The oxylipins were 
separated by using as analytical column anC18column 10 cm x 4,6mm, 5u. The 
mobile phase was generated by mixing eluent A ( 2% ACN 0.1 % Formic Acid ) and 
eluent B (methanol 0.009 % Formic Acid) and the flow rate was 0.200  mL/min . 
Starting condition was 98 % to 95% B in 9  minutes .Tandem mass spectrometry was 
performed using a turbo ion spray source operated in positive ions mode, and the 
selected reaction monitoring (SRM) mode was used for the selected analytes. A 
standard solution of 500 pg\uL of each metabolite was used for optimization of the 
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SRM transition. Standards were automatically (flow injection) tuned for ionization 
polarity, optimal declustering potential (DP), product ion, and collision energy (CE) 
using metabolite standard solutions via Agilent MassHunter Optimizer software.  
 
5.2.6 Data Processing 
 
Extracted mass chromatogram peaks of metabolites were integrated using Agilent 
MassHunter Quantitative Analysis software (B.05.00). Peak areas of corresponding 
metabolites are then used, as quantitative measurements, for assay performance 
assessments such as assay variation, linearity etc 
 
5.3 Results  
 
5.3.1 Mass spectral parameters selection 
The first step consisted in the selection of the best mass spectral parameters for 
the SRM detection of the analytes. Method sensitivity, limits of detection, and 
dynamic range were assessed using a mixture of two standards, 5-HEPE and 15-
HEPE. Thus, the two standard molecules were analysed to establish the optimal 
instrument settings for each compound. The SRM transitions for standard 
metabolites were properly selected by MassHunter Optimizer software by directly 
infusing each standard dissolved in the mobile phase to select the best product ion 
(Q3 ion) and optimize collision energy (CE), as well as declustering potential (DP).  
The most intense fragment ions were selected as the quantification ion for each 
molecule. The results are summarised in the Table 5.1.  
 
Compound 
Name 
Precursor 
Ion m/z 
Product 
Ion m/z 
Dwell 
(ms) 
Fragmentor  
(V) 
Collision 
Energy            
(V) 
Polarity 
5  hepe 
317,1 255 200 81 12 Positive 
317,1 59,1 200 81 7 Positive 
15  hepe 317,1 219,1 200 81 9 Positive 
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317,1 255 200 81 12 Positive 
 
Table 5.1 Precursor ion, product ions and mass spectral parameters optimized for all 
analytes. 
 
Figure5.2 shows the SRM chromatograms obtained for each target analyte with all 
transitions correctly occurring at the same retention time for the different species. 
Mass spectral parameters were optimised to obtain the best signal/noise ratio. The 
transition were selected in order to yield the best sensitivity and selectivity in the 
subsequent SRM analysis. 
 
Figure 5.2  XIC chromatograms obtained for the two target analytes  
5.3.2 Quantification and normalization 
 
Linearity and matrix effect were studied using standard solutions and matrix 
matched calibrations. Matrix matched calibration curves were built by spiking a 
diatom extract with 15 and 5 HEPE. Both standard and matrix matched calibration 
curves were constructed by plotting peak areas against concentration (pg/μl), and 
linear functions were applied to the calibration curves. Data were integrated by Mass 
Hunter quantitative software showing a linear trend in the calibration range for the 
standard molecules. The coefficients of determination (R2) were greater than 0.99.  
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Figure 5.3 : Standard calibration curves obtained for the two analytes 
 
The limits of detection (LODs), were defined as the lower limit of concentration 
below which the sample could not be revealed and were determined by making 10 
replies of blank samples spiked with low concentrations of each analyte. Calculations 
were made according to the following formula: LOD = 3*STD (STD=standard 
deviation).The LODs of 5-HEPE, and 15-HEPE resulted to be 0.61 pg/µl, 0.64  
pg/µl, respectively (Tab 5.2).  
In order to define the recovery in matrix and the LOQ, standard solutions were then 
prepared by spiking known amount of standards in the control sample. LOQ was 
calculated as s/n=10, resulting to be 1,85  pg/µl for 5-HEPE and , 1,90  pg/µl for 15-
HEPE  respectively. Recovery was calculated by comparing the extraction yield 
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before and after the addition of the different standard analytes into the control 
samples. Quantitation was achieved by using the calibration curves.  
 
Compound 
Name 
Linear 
range 
(pg/ul) 
Recovery 
% 
LOD 
(pg/ul) 
Limit of 
detection 
LOQ (pg/ul) 
Limit of 
quantification 
5  hepe 5 - 250  91 0,612 1,853 
          
15  hepe 5 - 250  93 0,640 1,9 
          
 
Table 5.2 Normalization parameters for all compounds. 
 
The lower LOD determined by SRM method in comparison to reported 
methods (Cutignano et al 2011) indicates that this method is highly sensitive for 
determination of the level of this class of molecules without any derivatization step. 
In particular, the LOD determined by SRM measurements resulted to be at least 10 
times lower than the values reported by other methods for the determination of these 
metabolite thus underlining the higher sensitivity of the proposed procedure and 
making this procedure well suited for in vivo determination. 
 
5.3.3 Oxylipins SRM method 
 
Our intent was to develop a rapid screening and quantifying method of targeted 
oxylipins in diatoms. Thus, to set up the SRM method we selected known oxylipins 
structures from literature data (Jang. 2009, Fontana 2007). In order to define the 
SRM parameters, precursor ions and fragment ions were selected taking advantage 
by characteristic oxylipins fragmentation pattern extensively studied by Fontana and 
co-workers in important papers (Fontana 2007). It was reported that, in MS/MS 
mode, synthetic fatty acid epoxydes, such as 8-hydroxy-9,10-epoxy-octadecanoic 
acid methylester (m/z 351 M+Na
+
)  typically give fragments arising by the heterolytic 
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break of the carbon-carbon bond of the epoxyde ring. This cleavage is very specific 
and allows the positioning of the functional group 
Analogously, cleavages of natural epoxy alcohol derivatives of fatty acids provide 
information for the location of both the epoxy and the alcohol groups present on the 
fatty acid alkyl chain. Because the charge resides always on the daughter ion 
containing the ester function, the cleavage mechanism of both epoxides and epoxy 
alcohol derivatives of polyunsaturated fatty acid is very unambiguous and allows the 
positioning of the functional group. Fragmentation typically generates daughter ions 
arising from losses of oxygen (M-16), rupture of C-C bond of the oxyrane ring and 
between alcoholic and epoxide functions, 
The fragmentation mechanism arising by α-cleavage is common to other keto acids 
and is sufficiently diagnostic to assign the position of the functional group (Fontana 
2007a).  
We firstly focused on known and already studied diatoms oxylipins, then we 
introduced in SRM method other oxylipins determined in matrices different from 
diatoms in order to obtain a metabolite panel as complete as possible. In general, 
these transitions were selected to yield the greatest sensitivity and selectivity for 
SRM quantification and are summarised in Table 5.3. 
 
precursor product name 
261 152 6-KHTrE 
261 113 6-KHTE 
263 154 6-HHTE 
263 107 9-HHTE 
265 149 6-HHTrE 
269 177 9-HHME 
279 179 12-Htre 
281 83 11,9-hephed 
295 195 13-HODE 
295 171  9-HODE 
300 152 6-KHTE 
301 257 EPA 
303 259 ARA 
313 201 9,10-DHOME con 12,13-DHOME 
317 174 8-hepe 
317 94 14-hepe 
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317 179 12-HEPE 
319 275 20-HETE 
319 219,2 14,15-EET 
319 219,1 15-HETE 
319 203,1 5-HETE 
319 191 5,6-EET 
319 179,2 12-HETE 
319 167 11,12-EET CON 11-HETE 
327 283 DHA 
329 211 9,12,13-TRIHOME 
333 190 7,5-hepete 
333 147 10,8-hepete 
333 126 16,14-hepete 
337 207 14,15-DiHETrE 
337 166,9 11,12-DIHETRE 
337 144,8 5,6-DIHETRE 
337 127 8,9-DIHETRE 
343 281,4 17-HDOHE 
361 272 19,20-DiHDoPe 
317 115 5-hepe 
317 255 5-hepe_15hepe 
317 219 15-hepe 
 
Table 5.3 The whole the SRM panel for the detection and quantification of 40  
oxylipins.  
 
5.3.4 Validation method 
 
A reliable sample extraction procedure was optimised keeping sample 
manipulation to a minimum. First, extraction and cleanup steps were developed in a 
control matrix containing no endogenous analytes and consisting in 100 mM 
phosphate-buffed saline (pH 7.4) 
Possible mass spectral interferences from biological specimens were 
investigated by adding a known amount of standards to the control. The absence of 
any signal except from 5 and 15-HEPE was verified by LC-MS/MS analysis using 
the SRM method containing the transitions selected for the two analytes. Moreover, 
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neither interferences nor carryover peaks were observed in the blank (matrix) 
samples by SRM analysis thus indicating the selectivity of the method.  
 
5.3.5  Oxylipins determination in Skeletonema marinoi extracts 
 
The reliability of the developed procedure and its applicability to routine practice 
were evaluated by determining the concentration of oxylipins in Skeletonema 
marinoi extracts. Diatoms samples were prepared by cells sonication and simple 
protein precipitation as described before; so they were directly analysed by tandem 
mass spectrometry in SRM positive ion scan mode. The experiments were performed 
in duplicate and averaged. Figure 5.4 showed the transition for each molecules.  
 
 
Figure 5.4 Xic chromatograms reported all transition monitored in a diatoms 
sample 
 
The panel of 40 oxylipins could be easily quantitated by SRM analysis by using the 
calibration curves (Table 5.4).  
 
Compound Name Abbreviation Site 1  Site 2 Site 3 Site 4 Site 5 Site 6 
10-hydroxy-8-epoxy-5Z,11Z,14Z,17Z-eicosatetraenoic 
acid 10,8-hepete 0,48 1,21 0,58 0,12 0,25 36,87 
(±)11,12-dihydroxy-5Z,8Z,14Z-eicosatrienoic acid 11,12-DIHETRE nd nd nd nd nd nd 
11(12)-epoxy-5Z,8Z,14Z-eicosatrienoic acid / (±)11-
hydroxy-5Z,8Z,12E,14Z-eicosatetraenoic acid 
11,12-EET / 11-
HETE nd nd nd 0,06 1,46 nd 
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 11-hydroxy-9- epoxy-8Z,11Z,14Z,17Z-eicosatetraenoic 
acid 11,9-hepete 0,04 0,06 0,01 0,31 0,63 nd 
(±) 12-hydroxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic 
acid 12-HEPE nd nd nd 0,13 1,82 nd 
12-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid 12-HETE nd nd nd nd 0,23 0,38 
12-hydroxy-5Z,8E,10E-heptadecatrienoic acid 12-Hhtre nd nd nd 0,10 0,59 nd 
(5Z,8Z,11Z)-14,15-Dihydroxy-5,8,11-eicosatrienoic acid  14,15-DiHETrE nd nd nd nd nd 2,73 
(±) 14(15)-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,
18,18,19,19,20,20,20-d11 acid 14,15-EET 0,01 nd nd nd nd nd 
(±) 14-hydroxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic 
acid 14-hepe nd 0,005 nd nd nd nd 
(±) 15-hydroxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic 
acid 15-hepe 17,58 1,09 66,43 nd nd 7,48 
15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid 15-HETE nd nd nd 0,06 nd nd 
16-hydroxy-14- epoxy-8Z,11Z,14Z,17Z-eicosatetraenoic 
acid 16,14-hepete 1,09 2,30 1,25 7,23 51,10 184,74 
(±) 17-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-
docosahexaenoic acid 17-HDOHE 0,005 0,02 0,02 0,54 7,07 216,13 
(+/-)19,20-DIHYDROXY-4Z,7Z,10Z,13Z,16Z 
DOCOSAPENTAENOIC ACID  19,20-DiHDoPe nd nd nd nd nd nd 
20-hydroxy-eicosatrienoic acid 20-HETE nd nd nd 0,02 nd 1,86 
(±) 5,6-dihydroxy-8Z,11Z,14Z-eicosatrienoic acid 5,6-DIHETRE nd nd nd nd 0,05 nd 
(±) 5(6)-epoxy-8Z,11Z,14Z-eicosatrienoic acid 5,6-EET nd nd nd nd nd nd 
(±) 5-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid 5-hepe 3,50 2,59 4,28 39,99 234,65 1389,13 
5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid 5-HETE 0,01 nd 0,01 0,17 0,63 5,62 
(7E,9Z,12Z)-6-hydroxyhexadeca-7,9,12,15-tetraenoic 
acid 6-HHTE nd nd 0,00 nd nd 1,10 
(7E,9Z,12Z)-6-hydroxyhexadeca-7,9,12-trienoic acid 6-HHTrE 0,16 0,37 0,06 nd nd 8,02 
(7E,9Z,12Z)-6-ketohexadeca-7,9,12,15- tetraenoic acid 6-KHTE nd 0,003 nd nd 3,03 1,10 
6-ketohexadeca-7,9,12-trienoic acid 6-KHTrE nd 0,003 nd nd nd nd 
7-hydroxy-5- epoxy-8Z,11Z,14Z,17Z-eicosatetraenoic 
acid 7,5-hepete nd 0,02 nd 0,07 nd nd 
8,9-dihydroxy-5Z,11Z,14Z-eicosatrienoic acid 8,9-DIHETRE nd nd nd nd nd nd 
8-hydroxy-5Z,9E,11Z,14Z,17Z-eicosapentaenoic acid 8-hepe nd nd 0,03 0,01 nd nd 
9,10,13-Trihydroxyoctadec-11-enoic acid 
9,10,13-
TRIHOME nd nd nd 0,15 1,84 nd 
(Z)-9,10-dihydroxyoctadec-12-enoic acid/ 12,13-
dihydroxyoctadec-12-enoic acid 
9,10-DHOME 
con 12,13-
DHOME nd nd nd 0,03 nd 1,48 
9,12,13-Trihydroxyoctadec-11-enoic acid 
9,12,13-
TRIHOME 0,01 nd 0,02 0,05 0,20 4,81 
9-hydroxy-7E-hexadecenoic acid 9-HHME nd 0,07 0,01 nd nd nd 
(6Z,10E,12Z,15)-9-hydroxyhexadeca-6,10,12,15-
tetraenoic acid 9-HHTE nd 0,25 0,07 0,86 2,23 21,09 
(6Z,9E,12Z)-hexadeca-6,9,12-trienoic acid  9-HHTrE 0,02 0,05 0,03 nd nd 1,40 
(±)-9-hydroxy-10E,12Z-octadecadienoic acid  9-HODE nd nd nd 0,37 63,74 nd 
(±)-13-hydroxy-9Z,11E-octadecadienoic acid 3-HODE nd 0,01 0,01 0,25 0,94 41,79 
docosahexaenoic acid  DHA 0,04 0,02 0,01 1,45 nd 834,54 
arachidonic acid ARA 0,01 0,003 0,01 0,09 0,95 23,80 
eicosapentaenoic acid  EPA 0,27 0,12 0,17 11,41 14,29 556,36 
 
Table5.4 Oxylipins identified in the microalgal pellets collected at each sampling 
site. Quantities for each compound are reported in ng/mg of proteins. 
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5.4 Discussion 
 
This method allowed simultaneous 40 oxylipins profiling thus expanding the 
knowledge of this class of molecules in diatoms. Once set up this SRM procedure led 
to a successful definition of quantitatively changes in oxylipins profiles in different 
single strain cultures of diatoms (Lauritano - manuscript submitted). However, this 
SRM method, even detailed is not exhaustive and can be easily extended to other 
oxylipins detection taking advantage by increasing interest in this field. Therefore 
enabling a quantitative profiling of hundreds to thousands of samples in a short time.   
Eicosanoids, derived from metabolism of Arachidonic acid and related 
polyunsaturated fatty acids  (Dennis, 2011), are bioactive lipids derived from 
polyunsaturated essential fatty acids involved in a wide variety of important 
physiological processes (Funk,2001). This entire and complex enzymatic system 
gives rise to hundreds of eicosanoids showing very similar structures, chemistries, 
and physical. properties . Up today more than 100 biologically active oxylipins have 
been identified (Dennis, 2011) and this number is constantly in progress thus 
indicating the ever increasing interest in this field. In this respect, new sensitive and 
easily handling analytical methods for their characterization are needed. 
It was set up a  simple and rapid method for the simultaneous direct measurement of 
oxylipins in diatoms extract based on HPLC fractionation and tandem mass 
spectrometry in multiple reaction monitoring mode avoiding any derivatization step . 
Because of the complexities of biological samples, a hyphenated technology is a 
common choice for metabolomics, among which, LC/MS has been widely used in 
recent years. Mass spectrometry (MS) has been the best selection because of its high 
sensitivity, specificity (molecular weight detection), low cost, and coupling 
capability to separation technologies. Among different types of mass spectrometers, 
a triple quadruple mass  spectrometric  optimal for targeted metabolomics, based on 
its high sensitivity, high specificity, and excellent quantitation ability. MS spectral 
integrated approach had provided sufficient data for a qualitative and quantitative 
metabolite analysis in marine diatoms, demonstrating  that , also at the end of a 
natural diatom bloom, diatoms release a series of secondary metabolites, most 
represented by oxylipins, that are deterrent for their predators (i.e. inducing a 
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reduction in the egg production and hatching success), but at the same time copepods 
activate a series of defense systems (e.g. the activation of the chaperonine HSPs, 
detoxification enzymes and inhibitor of apoptosis IAP) that may indicate a copepod 
stress response (Lauritano, .manuscrip submitted).  
The simultaneous, sensitive, fast and reproducible measurement of these metabolites 
might be useful in the highlighting the cell physiological status. The final goal of this 
work was to propose a general protocol for diatoms characterization avoiding 
methods that are time consuming and labour intensive and do not allow the 
processing of large numbers of samples for metabolic profiling. 
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6 Metabolomics and degenerative diseases 
6.1 Introduction 
 
Clinical diagnosis of major neurological disorders, for example Alzheimer's disease 
and Parkinson's disease, on the basis of current clinical criteria is unsatisfactory. 
Emerging metabolomics is a powerful technique for discovering novel biomarkers 
and biochemical pathways to improve diagnosis, and for determination of prognosis 
and therapy. Identifying multiple novel biomarkers for neurological diseases has 
been greatly enhanced with recent advances in metabolomics that are more accurate 
than routine clinical practice. Cerebrospinal fluid (CSF), which is known to be a rich 
source of small-molecule biomarkers for neurological and neurodegenerative 
diseases, and is in close contact with diseased areas in neurological disorders, could 
potentially be used for disease diagnosis  (Zhang AH1 2013) . 
Metabolomics analytical platforms and informatics tools are being used to map 
potential biomarkers for a multitude of disorders including those of the central 
nervous system (CNS) and are enabling us to describe detail perturbations in many 
biochemical pathways and links among these pathways this information is key for 
development of biomarkers that are disease-specific (Quinones MP 2009). 
Chemical synthesis of amino acids produces a 1:1 ratio of  D and L-amino acids. 
About 50 years ago, scientists believed that D-AAs do not exist in living organisms. 
D-amino acids are believed to have been excluded in the process of evolution, as all 
proteins in living things on earth are composed of L-amino acids. Studies in the last 
decades have shown that D-AAs are widely present in the tissues of higher 
organisms, including humans. Recent studies have determined the involvement of D-
amino acid  in diseases closely related to aging process and age-related disorders, 
such as cataracts and Alzheimer’s disease. 
 D-serine plays an important role in neuroplasticity, memory, and learning; D-
aspartate is involved in developmental and endocrine functions. The main pathways 
for the appearance and metabolism of D-AAs have been described. The 
pathogenicity of D-AAs is associated with excess activation of NMDA receptors and 
incorporation into normal protein molecules (conformational changes), which results 
in functional inactivation of the protein or its toxicity, and an increase in the 
82 
 
concentration of reactive oxygen species (oxidative stress) during disintegration of 
D-AAs by D-AA oxidase (DAAO). The level of D-AAs in biological fluids, the 
activity of enzymes, and mutations in genes that encode these enzymes may be used 
as a diagnostic marker in some diseases (Chervyakov A. V. 2011). 
Temporal regulation of  D- aspartate content depends on the post-natal onset of D- 
aspartate oxidase expression, the only known enzyme able to catabolize this D-amino 
acid. Pharmacological evidence indicates that D-aspartate binds and 
activates NMDA receptors (NMDARs). To decipher the physiological function of D- 
aspartate in mammals, in the last years, genetic and pharmacological mouse models 
with abnormally higher levels of this D-amino acid have been generated. Overall, 
these animal models have pointed out a significant neuromodulatory role for D- 
aspartate in the regulation of NMDAR-dependent functions (Errico F 2013). 
The involvement of D-Asp in the regulation of the synthesis and/or release of 
different hormones has been clearly demonstrated. However, its biological 
significance in the brain is still obscure. D-Asp appears with a peculiar temporal 
pattern of localization, being abundant during embryonic development and strongly 
decreasing after birth. This phenomenon is the result of the postnatal onset of D-
Asp oxidase (DDO) expression, the only known enzyme that strictly controls the 
endogenous levels of D-Asp. The pharmacological affinity of D-Asp for the 
glutamate site of NMDARs has raised the intriguing question whether this D-amino 
acid may have some in vivo influence on responses mediated by this subclass of 
glutamate receptors. In order to unveil the physiological function of D-Asp and of its 
metabolizing enzyme, genetic and pharmacological approaches have been recently 
developed. It has now become possible to generate animal models with abnormally 
elevated levels of D-Asp in adulthood based on the targeted deletion of the Ddo gene 
and on the oral administration of D-Asp. These animal models have thus highlighted 
that D-Asp has a neuro modulatory role at NMDARs in brain areas where they 
regulate crucial nervous functions. Indeed, abnormally high D-Asp levels in the 
hippocampus are able to strongly enhance NMDAR-dependent LTP and, in turn, to 
facilitate spatial memory of mice. Moreover, in both mutant and treated animals, this 
deregulated D-Asp content completely suppresses striatal LTD, most likely via over 
activation of NMDARs. The later synaptic plasticity alteration resembles that 
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produced by chronic administration of haloperidol and is probably the 
neurobiological substrate responsible for the attenuation of prepulse inhibition 
deficits induced by amphetamine and MK-801 in Ddo knockout and D-Asp-treated 
mice. These in vitro and in vivo findings, together with others reported in this 
review, support a neuromodulatory action for D-Asp at glutamatergic synapses. In 
addition, they suggest that this D-amino acid may play a potential beneficial role in 
conditions related to a pathological hypo functioning of NMDARs in the mammalian 
brain (F. N. Errico 2013).   
Due to its physiological relevance, a number of different methods have been 
proposed to detected d-Asp, including gas chromatography, high-performance liquid 
chromatography, high-performance capillary electrophoresis and enzymatic 
procedures (Hamase 2002). 
The most difficult part of this analysis is the enantio separation of d-Asp from l-Asp, 
since their chemical and physical properties, except configuration, are similar. Chiral 
HPLC sensitive separation methods for the determination of d-Asp levels in tissue 
samples have been developed (Maier 2001 Nguyen, 2012). 
Nowadays, automatic rapid HPLC tandem mass spectrometry (LC-MS/MS) has 
become the technique of choice for metabolite analyses due to its capability to 
simultaneously separate and quantitative many specific molecules in multi 
component mixtures. Petritis and co-workers successfully performed simultaneous 
chiral separations of underivatized amino acids have by using a teicoplanin-based 
chiral stationary phase and used ion spray tandem mass spectrometry for their 
ionisation and detection (Teleki A 2015).  
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6.2 Material and methods 
 
6.2.1 Chemicals and reagents 
 
N-methyl D-Asp (NMDA), D-Asp, L-Asp, were purchased from Sigma-
Aldrich. All the solutions and solvents were of the highest available purity and were 
suitable for LC–MS analysis and purchased from J. T. Baker (Phillipsburg, NJ). All 
stock solutions were stored at −20 °C. Tissue samples derive from Ddo knockout 
mice (Ddo
-/-
) brains. 
 
 
6.2.2 Preparation of Standard solutions 
 
The stock solutions were prepared by adding 1.00 mL aliquots of each analyte 
to a 10 mL volumetric flask and bringing the standard to volume with methanol to 
yield a standard solution with 1000 ng/mL of each analyte. The stock solutions were 
stored at −20 C until the analysis.. 
 
6.2.3 Individual Standard Solution 
 
Final 2000 pg/μl  individual analyte standard solutions were prepared, by 
serious dilution from stock solutions, and were used for calibration curves. Standard 
mixtures for each analyte were prepared as follows: 0.5, 1,0, , 25, 50, 125, 200, 300, 
pg/μl for D-Asp; 1, 5, 25, 50, 80, 125 pg/μl for L-Asp; 0,25, 2,5, 5, 10, 25, 50 for 
NMDA having higher, medium, and lower measuring sensitivities, respectively,  All 
standards were kept at -20ºC before LC MS/MS analysis. 
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6.2.4 Sample preparation 
 
All tissues were homogenized by sonication in Tris buffer (Tris-HCl 50mM 
pH 8) until a clear solution was obtained, and stored at −20 C until the time of 
analysis. For an initial screening extraction batch run, the control tissue was fortified 
in triplicate at three different target levels (50, 100 and 200 pg/μl )by adding the s 
standard solution containing same concentration of the three analytes to a 200 μl of 
homogenized control tissues (wt) corresponding to 0.5-g portion of control tissue. 
Aliquot of 0.6 ml of methanol was added (0.2ml) to each sample and the tube was 
mechanically shaken vigorously for 5min. The tube was centrifuged at 10000rpm 
(7600 rcf) at 10 C for 10min. Using a Pasteur pipette, the upper organic layer was 
transferred into a centrifuge tube. 0.2 ml of upper organic layer was filtered through 
a 0.2-μm PTFE syringe filter (Pall Acrodisc 13mm) into an LC vial for analysis. 
 
 
6.2.5 LC–MS/MS instrumentation and condition 
 
2μl of supernantant were analysed by using a 6420 triple Q system with a 
HPLC 1100 series binary pump (Agilent, Waldbronn, Germany). The enantiomers 
were separated by using as analytical column an Astec chirobiotic T column 10 cm x 
4,6mm, 5μm. The mobile phase was generated by mixing eluent A (0.1 % Formic 
Acid in 2% ACN) and eluent B (0.009 % Formic Acid,  methanol) and the flow rate 
was 0.200 mL/min. Starting condition was 50% to 95% B in 6 min. 
Tandem mass spectrometry was performed using a turbo ion spray source operated in 
positive mode, and the selected reaction monitoring (SRM) mode was used for the 
selected analytes.  
A standard solution of 500 pg/μl of each metabolite was used for optimization of the 
SRM transition. Metabolites were automatically (flow injection) tuned for ionization 
polarity, optimal declustering  potential (DP), product ion, and collision energy (CE) 
using metabolite standard solutions via Agilent MassHunter Optimizer software.  
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6.2.6 Data Processing 
 
Extracted mass chromatogram peaks of metabolites were integrated using Agilent 
MassHunter Quantitative Analysis software (B.05.00). Peak areas of corresponding 
metabolites are then used, as quantitative measurements, for assay performance 
assessments such as assay variation, linearity etc. 
 
 
6.3 Results 
 
The entire analytical procedure including the assessment of sensitivity, limits of 
detection, and dynamic range was developed using standard metabolite solutions. 
 
6.3.1 Enantiomeric separation 
 
An equimolar mixture of D- and L-Asp was resolved on a HPLC Chirobiotic 
chiral phase column consisting of the amphoteric glycopeptide Teicoplanin 
covalently bound to a 5µm spherical silica gel through multiple covalent linkages. 
Teicoplanin contains 23 chiral centers surrounding four pockets or cavities with 
hydrogen donor and acceptor sites readily available. This type of arrangement is 
known to be highly favorable for a number of enantiomeric separations. Isocratic 
elution of the enantiomers was accomplished by an unbuffered mixture of methanol 
and acetonitrile containing a small amount of formic acid providing an optimal 
coupling with the following mass spectral analysis. Figure 6.1 shows the total ion 
current (TIC) chromatogram obtained for the analysis of 100  pg/μl standard mixture 
solution showing a good peak shape for both analytes. Several injections of the 
standard mixture were carried out to ensure reproducibility of retention times. 
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Figure 6.1- Total ion current (TIC) chromatogram for the analysis of 100 ng/ml 
standard mixture solution of D-Asp, L-Asp and NMDA  
 
6.3.2 Mass spectral parameters selection 
 
Next step consisted in the selection of the best mass spectral parameters for the 
SRM detection of the analytes. D-, L-Asp and NMDA were individually infused to 
establish the optimal instrument settings for each compound. Experimental tuning 
was used to decide ionization polarity, to select the best product ion (Q3 ion) and to 
optimize both the collision energy (CE) and the declustering potential (DP). All 
tuning data were manually examined to ensure proper selection of ionization polarity 
and product ion; the results are summarised in Table 6.1.  
Compound 
Name 
Precursor 
Ion (m/z) 
Product 
Ion 
(m/z) 
Dwell 
(ms) 
Fragmentor 
(V) 
Collision 
Energy 
(V) 
Polarity 
L Asp 
134,00 116,00 200 81 1 Positive 
134,00 88,00 200 81 8 Positive 
134,00 74,00 200 81 9 Positive 
D Asp 
134,00 116,00 200 81 1 Positive 
134,00 88,00 200 81 8 Positive 
134,00 74,00 200 81 9 Positive 
NMDA 
148,00 88,00 200 81 9 Positive 
148,00 42,00 200 81 25 Positive 
 Table 6.1 Mass spectral parameters for the three analytes . 
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The SRM transitions (namely the best fragment ions) were properly selected for each 
metabolite by the MassHunter Optimizer software during direct infusion of analytes 
dissolved in the mobile phase. Figure 6.2 shows the SRM chromatograms obtained 
for D-Asp, L-Asp and NMDA showing a good selectivity for all analytes, with all 
transitions correctly occurring at the same retention time. 
 
  
Figure 6.2. LCMSMS chromatogram showing the SRM transitions for D-Asp, L-Asp 
and NMDA. 
 
 
6.3.3 Sample treatment 
 
First, a reliable sample extraction procedure had to be optimised keeping 
sample manipulation to a minimum because of the low concentration of D-Asp 
occurring in most biological samples. Target analytes were extracted from freeze-
dried specimens of mouse brain tissues following a two-steps procedure consisting in 
sonication of the sample and protein precipitation prior to LC-MS/MS analysis. 
Different buffers including  Ammonium Bicarbonate 10mM pH7.5, Ammonium 
Bicarbonate 50mM pH 8.0, Tris-HCl 50mM pH 8.0, Hepes 50mM pH 8.0, and 
sonication parameters (from 10 to 120 min with 10 min increments) were evaluated. 
Each test sample was then divided in three aliquots and the analytes extracted in the 
supernatant by precipitation of the protein components using different solvent 
systems (acetonitrile, ethanol, methanol).  
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 The different conditions explored were reported in Table 6.2. All test samples were 
then analysed by the SRM LC-MS/MS procedure to evaluate the best conditions for 
sample preparation and the recoveries. The best results were obtained by dissolving 
the sample in Tris-HCl 50mM pH 8.0 followed by sonication for 10 min. Finally, 
methanol was selected as the best solvent for protein precipitation. Extending the 
precipitation time beyond 30 min (i.e., up to 2 hours) did not increase the analyte 
recovery. Experiments were performed in duplicate and averaged 
.  
Buffer Solvent Recovery (%) 
Ammonium Bicarbonate 10mM pH7.5 
methanol 38 
Ethanol 14 
acetonitrile 11 
Ammonium Bicarbonate 50mM pH 8.0 
methanol 41 
Ethanol 25 
acetonitrile 13 
Tris-HCl 50mM pH 8.0 
methanol 93 
Ethanol 36 
acetonitrile 19 
Hepes 50mM pH 8.0 
methanol 41 
Ethanol 26 
acetonitrile 18 
Table 6.2: Different extraction conditions and averaged percentage (%) of recovery 
for the three analytes. Conditions yielding the highest recovery for all three analytes 
were selected. 
 
 
Possible mass spectral interferences from biological specimens were investigated. 
Thus a  control matrix  only containing L-Asp was prepared by using a sample of 
adult mouse brain treated with D-Asp oxidase in order to completely remove 
endogenous D-Asp and NMDA. The absence of any amount of free D-Asp in the 
adult mouse sample used as matrix control was verified by LC-MS/MS analysis 
using the SRM method.  
The absence of any amount of free D-Asp in the adult mouse sample used as matrix 
control was verified by LC-MS/MS analysis following the procedure outlined above. 
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Neither interferences nor carryover peaks (i.e., signal below LOD) were observed in 
the blank samples by SRM analysis.. 
 
6.3.4 Validation method  
 
Linearity and matrix effect were studied using standard solutions and matrix 
matched calibrations. Matrix matched calibration curves were built by spiking 
control tissue with L-Asp, D-Asp and NMDA. Both standard and matrix matched 
calibration curves were constructed by plotting peak areas against concentration 
(pg/μl), and linear functions were applied to the calibration curves. Data were 
integrated by Mass Hunter quantitative software demonstrating that the method was 
linear (r≥0.999) in the calibration range for all molecules. The signal corresponding 
to L-Asp was corrected for the presence of the endogenous metabolite in the control 
matrix. As an example, Figure 3 shows the standard calibration curves obtained for 
the three analytes. The matrix effect was calculated as the percentage of the matrix 
matched calibration slope (B) divided by the standard calibration slope (A). We 
obtained a matrix effect calculation (B/A x 100) of 11-15% for the three analytes.  
The limits of detection (LODs), were defined as the lower limit of concentration 
below which the sample could not be revealed and were determined by making 10 
replies of blank samples spiked with low concentrations of each analyte. Calculations 
were made according to the following formula: LOD = 3*STD (STD=standard 
deviation).  
The LODs of D-Asp, L-Asp and NMDA resulted to be 0,52pg/µl for D-Asp, 0,46 pg/ 
µl for  L-Asp and 0,54 pg/µl for NMDA, respectively.  
The precision (%RSD = 3.1–9.0) and accuracy (%RE =9.6–10.3) at different 
concentration levels, as reported before for each metabolite were calculated and 
resulted to be, reliable for the quantitative measurement of these metabolites in brain 
tissues. Data were collected over a period of 10 days and each measurement 
represents the average of 3 experiments. Table 3 reports the determined parameters 
for L-Asp, D-Asp and NMDA. The coefficients of determination (R2) were greater 
than 0.99 for all analytes. 
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In order to define the recovery in matrix and the LOQ, standard solutions were then 
prepared by spiking known amount of D-Asp, L-Asp and NMDA in the control 
mouse brain sample. Tissue samples were weighed and sonicated using the 
conditions previously defined; the metabolites were extracted and analysed by the 
LC-MS/MS procedure. The endogenous background of each analyte was corrected in 
the Mass Hunter software by calculating the non-spiked signal. LOQ was calculated 
as s/n=10, and resulted to be 1.57 pg/ul for D-Asp, 1.41 pg/ul for L-Asp and 1.64 
pg/ul for NMDA, respectively. Recovery was calculated by comparing the extraction 
yield before and after the standard addition of the different analytes into the control 
tissue samples 
Quantitation was achieved by using the calibration curves. Recovery for each analyte 
was better than 90% (see Figure 6.3) 
 
 
92 
 
 
 
Figure 6.3: Standard calibration curves obtained for the three analytes. 
 
Compound 
LOD 
(pg/ul) 
LOQ 
(pg/ul) 
Linear 
range 
(pg/ul) 
50 pg/ul 100 pg/ul 200 pg/ul 
d-Asp 0,52 1,57 1-125 73.9±1.1 87.8±9.4 106.8±1.3 
L-Asp 0,46 1,41 1-125 75.9±1.3 88.1±9.8 108.2±1.1 
Nmda 0,54 1,64 0,25-50 74.9±1.5 91.4±9.1 104.1±1.6 
 
Table 6.3. Validation parameters of the analytical method developed for L-Asp, D-
Asp and NMDA determination 
 
The reliability of the developed procedure and its applicability to routine 
practice were evaluated by determining the concentration of D-Asp, L-Asp and 
NMDA in several mouse brain tissues at different times of development as reported 
in Table 4. Freeze-dried specimens from mouse brain tissues were sonicated and 
precipitated according to the simple developed method, avoiding heavy sample 
handling, and directly analysed by tandem mass spectrometry in SRM scan mode. 
The analytes concentrations were calculated in pg/µl and then expressed in nmol/g of 
brain tissue in order to perform a comparison with data presented in the literature. 
 As an example, Figure 6.4 shows the TIC (Figure 6.4A) and the SRM transitions 
(Figure 6.4B) registred for the three molecules in a sample from prefrontal cortex of 
knockout mouse. Following SRM analysis, the three metabolites could be easily 
quantitated (see Table 6.4). 
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Figure 6.4A: TIC registred for the three molecules in a sample from prefrontal 
cortex of knockout mouse.  
 
 
 
 
 
Figure 6.4B: SRM registred for the three molecules in a sample from 
prefrontal cortex of knockout mouse. 
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L-Asp nmol/g   errore  
Pfc1 Ddo
+/+
 8183,1 ± 581,21 
Pfc2 Ddo
-/-
 9827,78 ± 923,81 
Pfc3 Ddo
+/+
 10592,36 ± 995,68 
Pfc4 Ddo
-/-
 9985,22 ± 873,84 
           
  D-Asp nmol/g   errore  
Pfc1 Ddo
+/+
 112,82 ± 0,21 
Pfc2 Ddo
-/-
 5144,59 ± 192,3 
Pfc3 Ddo
+/+
 127,99 ± 1,41 
Pfc4 Ddo
-/-
 5325,89 ± 274,45 
    
          
NMDA nmol/g    errore  
Pfc1 Ddo
+/+
 1,17 ± 0,36 
Pfc2 Ddo
-/-
 2,93 ± 1,54 
Pfc3 Ddo
+/+
 1,8 ± 0,26 
Pfc4 Ddo
-/-
 2,29 ± 0,34 
 
Table 6.4. Determination of  L-Asp, D-Asp and NMDA in samples from mouse 
prefrontal cortex by SRM analysis. Ddo+/+ , wild type mouse; Ddo-/-, D-aspartate 
oxidase (DDO) knockout mouse. 
  
  
Finally, the same analysis was performed on prefrontal cortex samples from 
both wild type and knockout mice for Ddo gene (Ddo
+/+
 and Ddo
-/-
,respectively). 
Figure 6.5 showed the results obtained by the LC-MS/MS procedure demonstrating 
that in Ddo
-/-
 mice sample the D-Asp levels are much higher compared to Ddo
+/+
 
littermates. 
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 Moreover, the D-Asp/L-Asp ratio determined by LC-MS/MS (0.012 for Ddo
-/-
 mice 
and 0.441 for Ddo
+/+
, see Fig 6.6) was approximately coincident with those 
previously obtained by HPLC measurements (0.019 for Ddo
-/-
 mice and 0.624 for 
Ddo
+/+
,manuscript in preparation). 
 
 
 
Figure 6.5 The results obtained by the LC-MS/MS procedure are reported. Ddo-/- 
mice sample showed a much higher of d-Asp levels when compared to Ddo+/+ 
littermates.  
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6.4 Discussion 
 
Many in vivo and in vitro studies have suggested that D-Asp has a crucial role in 
NMDA receptor-mediated neurotransmission playing very important functions in 
physiological and pathophysiological processes. Evidence collected in mouse models 
with increased levels of D-Asp has shown that this D-amino acid enhances 
hippocampal NMDAR-dependent synaptic plasticity, dendritic morphology and 
spatial memory. In line with the hypothesis of a hypo function of NMDARs in 
schizophrenia, it has been shown that increased D-Asp levels can improve brain 
connectivity and protect against sensorimotor gating deficits and abnormal activation 
of brain circuits induced by psychostimulant drugs. In healthy humans, genetic 
variation predicting reduced DDOmRNA levels in post-mortem prefrontal cortex is 
associated with prefrontal phenotypes relevant to schizophrenia (F. N. Errico 2012,). 
These crucial biological functions trigger the need for a simple, reliable and effective 
methodology to quantitative the levels of d-Asp and its derivative NMDA in brain 
tissues, as the alteration of their amounts would be of invaluable clinical and 
diagnostic value. 
We describe a simple and rapid method for the simultaneous direct measurement of 
free D-Asp, L-Asp and NMDA in brain tissue based on chiral fractionation of 
enantiamers and tandem mass spectrometry in multiple reaction monitoring mode 
avoiding any derivatization step. As D-Asp occurs at very low concentration in most 
biological samples, a reliable extraction procedure with minimum sample handling 
was first optimised (Fontanarosa, 2016).   
Detection of D-Asp, L-Asp and NMDA by mass spectrometric methodology has a 
number of advantages. Purification of the samples to remove organic impurities in 
tissues prior to HPLC detection was unnecessary in the LC-MS/MS method, making 
the analytical procedure simpler and faster. 
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The SRM method allowed us to discriminate the target metabolites within the very 
complex mixture originated from tissue extracts. D- and L-Asp were distinguished 
by their retention time on chiral chromatography and all three compounds could be 
unambiguously identified by their specific SRM transitions thus avoiding any 
derivatization step. All the analytical parameters, LODs, LOQs were determined.  
Finally, the developed procedure was applied to the quantitative determination of D-
Asp and L-Asp from prefrontal cortex samples from both Ddo+/+ and Ddo-/-mouse, 
an animal model in which the Ddo gene has been genetically deleted, and the results 
were compared with the same measurements carried out by HPLC. Determination of 
D-Asp and L-Asp could be easily obtained with no interference or decrease in 
sensitivity. As expected, D-Asp levels were much higher in the knockout mouse than 
in wild type. Moreover, measurement of the D-Asp/L-Asp ratio determined by LC-
MS/MS was in very good agreement with that obtained by HPLC (Karakawa S 
2015). 
In conclusion, the developed method provided to be a reliable and effective 
procedure for direct measurements of free D-Asp, L-Asp and NMDA in brain tissues 
and was successfully applied as a rapid screening procedure for detection of these 
metabolites levels in different mouse brain districts (manuscript in preparation).  
Low reagent costs together with the relative simplicity of sample preparation make 
the LC-MS/MS SRM method well suited, not only for research work but also in 
those laboratories with a tandem mass spectrometer, for the measurement of routine 
clinical samples. The methodology we developed allows simultaneous D-Asp, L-Asp 
and NMDA profiling but can be easily extended to different class of metabolites, and 
easily expandable at clinical samples screening. 
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7 Targeted proteomics: Insulin degrading enzyme, 
a case study 
7.1 Introduction 
 
Mass Spectrometry-based proteomics is actually considered a gold standard 
technique for protein analysis, ranging from global expression profiling to the 
identification of protein complexes and specific post-translational modifications. 
Recently, Selected Reaction Monitoring Mass Spectrometry (SRM-MS) has become 
increasingly popular in proteome research for the targeted quantification of proteins 
and post-translational modifications.  
Targeted proteomics is a powerful tool for protein identification in complex 
biological samples, by limiting the number of target proteins to be monitored, 
focuses on optimization of chromatographic instrumental methods and acquisition 
parameters, to obtain higher sensitivity, selectivity and performance for protein 
analysis in complex mixtures  (Liebler D. C. 2013). In particular, Mass Spectrometry 
Selected Reaction Monitoring (SRM) is emerging as a versatile platform for the 
systematic development of targeted protein arrays and alternative to the classical 
immune assay thus providing quantitative measures highly selective and specific for 
proteins useful as biomarkers, potential clinical tools useful for the diagnosis, 
prognosis and therapeutic monitoring (Picotti P. 2012). SRM assays enable the 
quantification of protein in a concentration range that goes from μg/mL to a few 
ng/mL without or reducing fractionation or enrichment strategies. 
Insulin degradation enzyme (IDE) is a  110-kDa zinc metalloprotease found in the 
cytosol of all cells involved in the degradation of a number of small proteins (<6 
kDa) including insulin and amyloid-β (Im 2007) . IDE has been intensively studied 
as a participant in the pathogenesis of diabetes and Alzheimer's syndrome 
(Duckworth 1998, Qiu 2006). 
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7.2 Material and methods 
7.2.1 Chemicals and reagents 
 
Recombinant human insulin degrading enzyme (IDE) were purchased from 
Sigma-Aldrich. All the solutions and solvents were of the highest available purity 
and were suitable for LC–MS analysis. All stock solutions were stored at −20 °C. 
7.2.2 Preparation of standards solutions 
 
A stock solution of IDE at 1 I0 μmol/mL) was prepared in 0.1% formic acid 
solvent and stored at −80 °C until use. Dilutions were subsequently performed to 
generate a calibration series at concentrations of 0.5 fmol/ µL, 1fmol/µL, 5 fmol/µL, 
10 fmol/µL, 25 fmol/µL, 50 fmol/µL, 75 fmol/µL). All standards were kept at -20ºC 
before LC MS/MS analysis. 
 
7.2.3 Reduction and carboamidomethylation 
 
Dried protein and hepatocytes pellet were dissolved in denaturation buffer: 
Guanidine 6M, Tris HCl 0.3M, EDTA 10mM at pH 8.0. 
Reduction was carried out by using a 10:1 DTT:cysteine molar  ratio. After 
incubation at 37°C for 2 h, iodoacetamide was added to perform 
carboamidomethylation using an excess of alkylating agent of 5:1 respect to the 
moles of thiolic groups. The mixture was then incubated in the dark at room 
temperature for 30 minutes. The alkylation reaction was stopped by addiction of 
formic acid, in order to achieve an acidic pH. 
The product was purified by precipitation, 100 µL volume of sample was treated by: 
 400 µL of CH3OH 
 100 µL of CHCl3 
 300 µL of water.  
The resulting solution was centrifuged for 5 minutes at 12000 rpm.  
The protein will be precipitated at the interface organic-inorganic phases. The 
supernatant was removed, and was added 300 µL of CH3OH. The resulting solution 
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was centrifuged for 5 minutes at 12000 rpm and it was clearly visible a protein pellet 
on the bottom of the Eppendorf. The supernatant was removed and sample was dried. 
7.2.4 Tryptic digestion 
Digestion of protein was carried out in AMBIC 10mM using trypsin at a 50:1 
protein:enzyme mass ratio. The sample was incubated at 37°C for 16 h. Then sample 
was dried.  
 
7.2.5 LC–MS/MS instrumentation and conditions 
 
Peptide mixture was analyzed by LC-MS/MS analysis using a Xevo TQ-S (Waters) 
with an ionKey UPLC Microflow Source coupled to an UPLC Acquity System 
(Waters). The LC program is shown in pictures below: 
 
Figure 7.1 : Ionkey and Source Parameters. 
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Figure7.2: LC method and Parameters. 
7.2.6 Data processing  
 
Proteotypic peptides, best transitions and collision energy were defined by Skyline 
software. Sample data acquisition, processing and quantitative analysis was carry out 
by  The TargetLynx™ Application Manager Software. 
 
7.3 Results  
7.3.1 Mass spectrometer parameters optimization 
 
The mass spectral parameters has been optimazed by using informatics tools as the 
software Skyline, which allows to maximize the sensitivity and specificity by 
identifying proteotypic peptide and for each peptide the three to five best transitions 
and  provides a collision energy predictions for major instrument manufacturers of 
QQQ-MS. The results are shown in the table below: 
 
PEPTIDE 
PRECURSOR 
m/z  
PRODUCT 
m/z  
Dwell 
(ms) 
Declustering 
Potential 
COLLISION 
ENERGY 
GWVNTLVGGQK 
[353-363] 
579,8 
915,5 50 80 20 
816,4 50 80 20 
702,4 50 80 20 
601,3 50 80 20 
 SLNNFR                   375,6 663,3 50 80 13 
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[668-673]     550,2 50 80 13 
436,2 50 80 13 
AFIPQLLSR              
[713-721] 
522,8 
973,5 50 80 18 
826,5 50 80 18 
713,4 50 80 18 
616,3 50 80 18 
EQLGYIVFSGPR 
[826-837] 
683,3 
1108,6 50 80 24 
995,5 50 80 24 
938,5 50 80 24 
775,4 50 80 24 
 
Table 7.1 Precursor ion, product ions and mass spectral parameters optimized for 
IDE. 
 
7.3.2 Quantification and normalization 
 
The transition and the experimental condition determinate in silico have been 
validated using a standard solution of the protein. For the realization of the 
calibration curve the product ion that having the greater signal intensity was chosen 
as "quantifier". The other transitions ,"qualifier", provide instead a confirmation of 
the correct identification of the molecule as it will have the same elution time. 
PEPTIDE 826-837 m/z 
683.3
PEPTIDE 353-363 m/z 
579.8
PEPTIDE 713-721 m/z 
522.8
PEPTIDE 668-673 m/z 
375.7
522.8>973.6
522.8>826.5
522.8>713.4
522.8>616.4
683.4>995.5
683.4>938.5
683.4>1108.6
683.4>775.4
579.8>915.5
579.8>816.4
579.8>702.4
579.8>601.4
375.7> 663. 
3
375.8> 
550.3
375.7> 
436.2
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Figure 7.3 Proteotypic peptides and best transitions choosen for IDE protein. 
Calibration curves were obtained by plotting chromatogram peak area against 
concentration (0.5 fmol/ µL, 1fmol/µL, 5 fmol/µL, 10 fmol/µL, 25 fmol/µL, 50 
fmol/µL, 75 fmol/µL). 
 
 
 
Figure 7.4 Calibration curves obtained for the four peptides. 
 
The lower limit of detection (LOD,) and the LOQ are defined, respectively, as the 
concentration level at which the analyte can be reliably detected in the sample under 
consideration and as the level at which the analyte can be detected and measured 
with sufficient precision.  
In order to account the matrix effect, serum samples were supplemented with known 
concentrations of standard protein (spike). In particular, Insulin Degrading Enzyme 
was spiked into human depleted serum in 10fmol concentration. 
106 
 
 
Figure 7.4 TIC chromatograms of proteotypic peptides in spiked matrix. 
 
Recovery value (%) was also calculated (Tab7.2). 
. 
PEPTIDE 
Linear 
range 
(fmolL/ul) 
Recovery 
% 
LOD 
(pg/ul) 
Limit of 
detection 
LOQ (pg/ul) 
Limit of 
quantification 
GWVNTLVGGQK 
[353-363] 
0,5-75 
75,2 0,8 2,5 
 SLNNFR                   
[668-673]     
0,5-75 
AFIPQLLSR              
[713-721] 
0,5-75 
EQLGYIVFSGPR 
[826-837] 
0,5-75 
 
Table 7.2 LOD, LOQ and recovery value for IDE protein. 
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7.3.3 Validation of the method 
SRM targeted approach for IDE identification and quantification was applied to 
analyze three fraction of hepatocytes lysate. The epatocytes pellets were hydrolyzed 
as previously described, dissolved in 200 ul 0.1% Formic acid in water and analysed 
by LC–MS/MS. Quantification was achieved by the external standard method by 
interpolation on calibration curves, specific for each transition, using the 
TargetLynx™ Application Manager Software. The protein amount is calculated as 
the average value of the peptides and take into account the recovery values (Tab 7.3). 
 
Concentration measured       
(ng/mg of Extract) 
0,5-1,8  
 
 
Table 7.3 Concentration range  determined in hepatocytes extracts. 
7.4 Discussionn 
 
Targeted protein quantification by SRM ion mode has emerged rapidly over 
the past 10 years as one of the most challenging tasks in proteomic and biochemistry 
field research.  
Proteomics quantification requires a more complex workflow respect to 
metabolomic, including an experimental design step to select the peptides suited for 
LC–MS measurements. The  method is  based on the identification of proteotypic 
peptides that uniquely and stoichiometrically represent the protein candidates of 
interest for quantitation. Several informatics tools such as the software Skyline, 
allows to maximize the sensitivity and specificity of the method by identifying 
proteotypic peptide and best transitions and  provides a collision energy predictions. 
The SRM assay for the analysis of IDE  has demonstrated the high specificity and 
sensitivity and its applicability to quantify this protein in complex matrix. 
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8 Targeted proteomics and metabolomics in 
Thyroide disease  
8.1 Introduction 
 
Biomarker research is one of the most interesting application in proteomics and 
metabolomics: different small molecule and  protein/peptide present in clinical 
specimens such as tissue, proximal fluids and blood have been discovered as 
potential clinical tools for diagnosis, prognosis and therapeutic prediction of the 
disease of interest. For this reason, quantitative measurement of metabolites and 
proteins is one of the major goals of biochemistry  (Liebler D. C. 2013).  
Identification and validation of putative biomarkers in complex biological samples 
requires an instrumental method that is fast, highly selective, and sensitive. The gold 
standard techniques to analyze proteins and metabolites in different organisms, 
tissues or fluids, are immuneassay as Elisa and RIA. But antibodies also may not 
distinguish highly similar homologues and sequence variants arising from 
polymorphisms and mutations and they can’t detect between different specific 
modification sites on proteins. 
Selected reaction monitoring (SRM) has been established as an important 
methodology for biomarker quantification for its ability to target specific peptide 
sequences, including variants and modified forms, and the capacity for multiplexing 
that allows analysis of dozens to hundreds of peptides.  
Congenital hypothyroidism with thyroid dysgenesis (TD) is a genetically 
heterogeneous disease. It’s a frequent human condition characterized by elevated 
levels of TSH in response to reduced thyroid hormone levels. Congenital 
hypothyroidism is a genetically heterogeneous disease. In the majority of cases 
studied, no causative mutations have been identified and very often the disease does 
not show a Mendelian transmission. However, in approximately 5% of cases, it can 
be a consequence of mutations in genes encoding the TSH receptor or the 
transcription factors TITF1, FOXE1 or PAX8. We report here that in mouse models, 
the combination of partial deficiencies in the Titf1 and Pax8 genes results in an overt 
TD phenotype that is absent in either of the singly deficient, heterozygous mice. The 
disease is characterized by a small thyroid gland, elevated levels of stimulating 
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hormone thyroid (THS)  levels, reduced secretion of thyroid hormones, 
triiodothyronine (T3), thyroxine (T4) and thyroglobulin biosynthesis, and high 
occurrence of hemiagenesis. The observed phenotype is strain specific, and the 
pattern of transmission indicates that at least two other genes, in additionto Titf1 and 
Pax8, arenecessary to generate the condition. These results show that TD can be of 
multigenic origin in mice and strongly suggest that a similar pathogenic mechanism 
may be observed in humans. (Amendola E. 2005).  
Genomics is an entry point for looking at the other ‘omics’ sciences. The information 
in the genes of an organism, its genotype, is largely responsible for the final physical 
makeup of the organism, referred to as the phenotype. However, the environment 
also has some influence on the phenotype. Low molecular weight compounds are the 
closest link to phenotype. 
For a holistic understanding of the biological behavior of a complex system, it is 
essential to follow, as unambiguously as possible, the response of an organism to a 
conditional perturbation at the transcriptome, proteome and metabolome 
levels (Oliver D. J. 2002) (Sweetlove L.J. 2003).  
These three levels of expression profiling provide a complete picture of the RNAs, 
proteins and metabolites that enable one to: infer relevant associations between 
macromolecules; identify functional linkages between phenotypic expressions; and 
construct models that quantitatively describe the dynamics of the biological system. 
Broad phenotypic analyses are essential if we are to progress from prediction to 
experimental validation of gene function (Bino RJ1 2004). 
In order to highlight the close link between genomics proteomics and metabolomics 
and emphasize the effects on phenotype, a method, useful to quantify murine serum 
concentrations of three biomarkers T3, T4 (Marotta P 2014) and THS involved in the 
regulation of endocrine activity of the thyroid, has been developed, in collaboration 
with the Department of Molecular Medicine and Medical Biotechnology , University 
of Naples Federico II and IRGS – Biogem.  
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8.2 Material and methods 
8.2.1 Chemicals and reagents 
 
Murine synthesized peptides  were purchased from Primm (DFIYR, LFLPK). 
Triiodothyronine (T3) and thyroxine (T4) were purchased from Sigma-Aldrich All 
the solutions and solvents were of the highest available purity and were suitable for 
LC–MS analysis. All stock solutions were stored at −20 °C. 
 
8.2.2 Preparation of standards solutions 
 
Stock solution of  two peptides  were prepared at 10 mg/mL by adding  1 mL 
of 0.1% formic acid solvent to each peptides Dilutions were subsequently performed 
to generate a calibration series at concentrations of 0.5 fmol/ µL, 1fmol/µL, 5 
fmol/µL, 10 fmol/µL, 25 fmol/µL, 50 fmol/µL, 75 fmol/µL, 100fmol/ul). Standard 
solutions of T3 and T4  were prepared  at different concentrations (0.5, 1,0, 5, 10, 25, 
50, 100  pg/μl)  by serious dilution and were used for calibration curves.  
8.2.3 Sample preparation 
 
Blood samples were obtained from the tail vein, under light anesthesia, and 
collected in tubes without the presence of anticoagulant. After coat formation the 
samples were centrifuged and the recovered sera were kept frozen at −20 °C until 
assayed 
8.2.3.1 Metabolites  
  
 100 µl of 145 samples of mouse serum were treated with 300 µl of cold 
ethanol. The mixtures were stored at -20°C for about 30 minutes followed by 
centrifugation at 10000 rpm for 10 min at room temperature. The clear supernatant, 
subsequently subjected to analysis, was transferred to a 1.5-mL tube and stored at -
20°C. 1 ul of supernantant was used for analysis. In order to validate the 
performances of the method serum samples were spiked, prior to the extraction, with 
appropriate concentrations of the standard mixture of targeted analytes. 
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8.2.3.2 Protein  
To eliminate major proteins interference in murine plasma, in particular 
Albumin (~45 mg/mL) and IgG (~10 mg/mL), representing approximately 65% and 
15% of total plasma proteins, respectively, plasma samples were subjected to sample 
clean-up used immunoaffinity depletion.  
 
8.2.3.3 Reduction and carboamidomethylation 
Serum samples and standard peptides were dissolved in denaturation buffer:  
Guanidine 6M, Tris HCl 0.3M, EDTA 10mM at pH 8.0. 
Reduction was carried out by using a 10:1 DTT:cysteine molar  ratio. After 
incubation at 37°C for 2 h, iodoacetamide was added to perform 
carboamidomethylation using an excess of alkylating agent of 5:1 respect to the 
moles of thiolic groups. The mixture was then incubated in the dark at room 
temperature for 30 minutes. The alkylation reaction was stopped by addiction of 
formic acid, in order to achieve an acidic pH. 
The product was purified by precipitation, 100 µL volume of sample was treated by: 
400 µL of CH3OH 
100 µL of CHCl3 
300 µL of water.  
The resulting solution was centrifuged for 5 minutes at 12000 rpm.  
The protein will be precipitated at the interface organic-inorganic phases. The 
supernatant was removed, and was added 300 µL of CH3OH. The resulting solution 
was centrifuged for 5 minutes at 12000 rpm and it was clearly visible a protein pellet 
on the bottom of the Eppendorf. The supernatant was removed and sample was dried. 
8.2.3.4 Tryptic digestion 
Digestion of protein was carried out in AMBIC 10mM using trypsin at a 50:1 
protein:enzyme mass ratio. The sample was incubated at 37°C for 16 h. Then sample 
was dried.  
8.2.4 LC–MS/MS instrumentation and conditions 
 
SRM protein analysis of standard solution and serum samples was carry out  using a 
Xevo TQ-S (Waters) with an ionKey UPLC Microflow Source coupled to an UPLC 
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Acquity System (Waters).  For metabolites analysis was performed using a 4000 
QTrap ABSciex  coupled to Eksigent expressHT-ultra system  . For analysis the 
Eksigent  0.5 x100mm C18 HALO column was used  at a flow rate of 40 L/min 
with a 5% to 95% linear gradient in 6 min (A solvent 0.1% formic acid, 2% ACN in 
water; B solvent 0.1% formic acid, 5% water in ACN).   
8.2.5 Data processing 
The specific transitions and collision energy for the two peptides were defined by 
Skyline software. Sample data acquisition, processing and quantitative analysis was 
carry out by  The TargetLynx™ Application Manager Software. 
For metabolites, the acquisition methods were processed through software 
MassHunter Data Acquisition. 
8.3 Results and discussion 
 
8.3.1 Mass spectrometer parameters optimization 
 
Best transitions and mass spectral parameters optimized are shown in the table 8.1A 
and B.  
A 
Compaund 
Precursor Ion 
(m/z) 
Product Ion 
(m/z) 
Dwell (ms) 
Declastering 
Potential (V) 
Collision 
Energy (V) 
 
Polarity 
 
DFIYR 
357,1 
 
598,3 250 90 12 Positive 
451,2 250 90 12 Positive 
LFLPK 
309,2 
 
504,3 250 90 10 Positive 
357,2 250 90 10 Positive 
  
 
. B 
Compound 
Name 
Precursor 
Ion m/z 
Product 
Ion m/z 
Dwell 
(ms) 
Declustering 
Potential 
(V) 
Collision 
Energy            
(V) 
Polarity 
T3 651,9 605,7 250 80 20 Positive 
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651,9 197,1 250 80 80 Positive 
T4 
777,9 731,6 250 80 30 Positive 
651,9 322,8 250 80 90 Positive 
 
 Table 8.1 A and B. Specific transitions and instrumental parameters optimized  
 
8.3.2 Quantification and normalization 
 
The transition and the experimental condition determinate in silico have been 
validated using standard  solutions of T3, T4 and TSH in LC MS MS.  
 
 
 
Figure 8.1.a) Total  ion chromatogram for TSH peptides B) XIC cromathogram for 
T3 and T4. 
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The calibration curves were obtained by analysing all standard solutions at different 
concentrations. Good linearity (R2 > 0.9) is obtained for all compounds as shown in 
figure, both for metabolites and proteins. 
 
  
 
 
Figure 8.2 Calibration curves for standars mixture.  
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Limit of detection (LOD) , limit of quantification (LLOQ) and recovery were 
determined by addition of defined concentration of standard solution to the serum 
(Tab.8.2 and 8.3). 
 
 
PEPTIDE 
Linear range 
(fmolL/ul) 
Recovery % 
LOD (pg/ul) 
Limit of 
detection 
LOQ (pg/ul) 
Limit of 
quantification 
DFIYR 0,5-100 
86,80 2,50 7,50 
LFLPK 0,5-100 
 
Table 8.2 LOD, LOQ and recovery value for protein peptides. 
Compound 
Name 
Polarity 
Linear 
range 
(pg/ul) 
Recovery 
% 
LOD 
(pg/ul) 
Limit of 
detection 
LOQ (pg/ul) 
Limit of 
quantification 
T3 
Positive 
0,5-100 90 0,25   0,71 
Positive 
T4 
Positive 
0,5-100 95  0, 18  0,62 
Positive 
 
Table 8.3  LOD, LOQ and recovery value for metabolites. 
 
8.3.3 Validation of the method 
 
The SRM method so set up both for TSH and T3 and T4 has been applied to 
quantification of  this specific compounds in 145 murine serum sample.  
Quantitation was achieved by using the calibration curves. Recovery was calculated 
by comparing the extraction yield before and after the standard addition of the 
different analytes into the control samples.  
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Analyte Concentration range 
Phenotype normal Hypothyroidism 
T3 (pg/µL)  0,9 - 10 <0,1 
T4 (pg/µL)  9 -65 <0,5 
TSH (fmol/ul) 1,5- 2,6 6,5 - 16 
  
Table 8.4 Concentration mean value determined in murine serum. 
 
Subsequently, mice are divided in three experimental groups (OFF untreated 
controls, 1wkON treated for a week and the serum was collected immediately, 
1wkOFF were  treated for a  week and the serum was collected one week after the 
end of treatment), treated with a substance that induces hypothyroidism characterized 
by low T4 and high TSH. 
A recovery of thyroid function resulted  by T4  increase and TSH decrease  was 
observed (Fig8.3 ). 
 
 
 
Figure 8.3 T4 and TSH trand in experimental groups under the influence of a thyroid 
inibhitor 
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8.4 Discussion  
 
The identification of biomarkers for diagnosis, prognosis, therapy monitoring and 
toxicity is a major goal of biomedicine in the 21st century. These molecules are 
metabolites and proteins whose concentrations vary under the influence of 
endogenous and exogenous factors. For this reason the  main objective of the 
analysis of diagnostic compounds is their detection and quantification in biological 
samples like human plasma or urine. Clinical application almost invariably uses an 
antibody-based diagnostic approach such as ELISA or dipstick.  
Whilst this process has the potential to deliver clinically important markers, 
particularly within the cancer field, it may not represent the most efficient process 
since it requires the independent and sequential development of at least two 
analytical methodologies  with the disadvantage of high costs. 
Currently there is a growing interest in simultaneous analysis of multiple biomarkers 
characterizing a given condition. This means that multiwell screen will be needed 
with all the problems associated with the production of antibodies and cost. 
Furthermore, patient heterogeneity, variation during sample acquisition and storage, 
sample stability, dynamic range, modification status of analytes, macromolecular 
interactions and other factors all deeply influence the observed qualitative and 
quantitative characteristics of a potential biomarker. 
Confirmation and validation of putative biomarkers in complex biological samples 
requires an instrumental method that is fast, highly selective, and sensitive. Analytes 
quantification using selected reaction monitoring (SRM) has been established as an 
important methodology for biomarker quantification.  
The application of LC/MS/MS in SRM ione mode for protein and metabolite 
analysis compared to the current antibody-based automated immunoassays presented 
some advantage. First, it provide excellent selectivity and specificity regardless of 
the complexity of the serum. Second, it has a LOQs lower of the usual concentration 
range of  immunoassays. Third, the assay  is  simple and highly reproducible as well 
as being robust and able to accommodate high sample throughput.   
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The examples provided above clearly indicate the power of SRM methodology for 
sensitive quantification of proteins and metabolites biomarkers within complex 
mixtures in routine use. 
The results of quantitative determination of T3, T4 and TSH have made possible the 
genotype- phenotype correlation confirming the hypothesis of a multigenic origin of 
the alteration of the thyroid. 
The SRM assay for the analysis of TSH  has demonstrated the high specificity and 
sensitivity of the method resulting in a viable alternative to the official method 
ELISA.  
It has resulted particularly useful in research field thanks to its versatility for 
application in different organisms. 
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9 Conclusions 
9.1 SRM compared to other quantification techniques  
 
Targeted metabolomics and proteomics by SRM have shown the potential of 
becoming the technique of choice for the identification and quantification of specific 
compounds in biological matrix. 
A number of methods can produce metabolic signatures of biomaterials, including 
nuclear magnetic resonance (NMR), gas chromatography-mass spectrometry (GC-
MS), liquid chromatography-mass spectrometry (LC-MS), capillary electrophoresis- 
mass spectrometry (CE-MS), and so on.  
GC coupled to MS has been extensively used  in metabolome analysis because of its 
high separation efficiency and the easy interfacing of GC with MS. It can be used to 
analyze a wide range of volatile compounds and semi-volatile compounds through 
chemical derivatization. The volatile compounds include ketones, aldehydes, 
alcohols, esters, sulfides, some lipids, and so on. The semi-volatile metabolites 
include sugars, sugar-phosphates, sugar-alcohols, organic acids, amino acids, lipids, 
peptides, alkaloids, amines, amides, and so on. In addition to GC-MS, LC coupled to 
MS is useful tool for metabolomics studies. They can resolve and quantify multiple 
components in crude biological extracts in the nanomole to picomole and even 
femtomole range from as little as submicroliter volumes. LC-UV-MS is routinely 
used for metabolites quantification based on the peak area associated with UV 
signals. Currently LC-MS/MS is considered the workhorse of metabolites detection 
because of the fact that the derivatization of polar/on-volatile metabolites for GC-MS 
analysis is both time consuming and require fewer material compared to LC. 
Analytical methods based on affinity reagents, such as antibodies, have been 
routinely used in biological and biomedical research to measure the presence and/or 
quantity of target proteins by exploiting the antibody specificity and the direct or 
indirect detectability of a tag such as radioisotopes, enzymes and fluorophores. The 
methods with the lowest limit of detection have the potential to detect, in principle, 
low-abundance compounds, down to zeptomole detection limits. However, the 
development of reagents of suitable specificity and affinity to support the 
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unambiguous measurement of the target protein in a complex background remains 
challenging, expensive and arduous. A step toward increased multiplexing of affinity 
reagent–based assays was the development of protein arrays in which microarrays, 
chips or beads allow for the parallel, multiplexed screening of large numbers of 
proteins, in an automated manner, and with minimal consumption of sample and 
reagents. 
Another often used technique is the direct tagging of the target protein with a 
detectable and quantifiable label such as a fluorescent protein and its quantification 
by flow cytometry or microscopy techniques. The multiplexing capabilities are 
normally limited, and the introduced tag can potentially affect the localization, 
function, stability and expression of the target protein. These fusion proteins offer the 
possibility to quantify the amount of the target protein in single cells, thus revealing 
the cell-to-cell variability in expression and to provide information about the 
subcellular localization of proteins. Other techniques to quantify specific proteins in 
single cells are immunofluorescence, which can be applied to cells or tissue sections, 
and mass cytometry, which expands the multiplexing capabilities of single-cell 
probes by the use of multiatom elemental tags. However, both techniques rely on 
antibodies and thus have limitations associated with their use. 
  
9.2 Advantage of SRM  
 
In recent years there has been a rapid increase of targeted proteomics and 
metabolomics using SRM methods. As demonstrated in this thesis project, SRM 
offers several advantages, such as specificity, sensitivity, linearity and it ideally suits 
for multiple quantitative analysis. 
The selective nature of SRM reduces the likelihood of interference from matrix and 
other target compounds, allowing for the rapid analysis of more compounds in a 
single run. In addition, the capacity of monitoring more transitions simultaneously 
allows for greater security in the identification of specific target compound, reducing 
false positive. 
LC-SRM measurements showed that the range of analytes concentration accessible 
by direct LC-SRM is 4–5 orders of magnitude and that limits of detection at the low 
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attomole level can be routinely reached, even in complex samples at high 
reproducibility and throughput.  
Another important advantage is that the SRM analysis does not require a laborious 
step of sample pre-treatment or a detailed chromatographic separation offering the 
possibility of reducing the time analysis, including the extraction and data 
processing. 
SRM analysis are not limited to a single application area but it is a versatile 
analytical approach. Laboratories working in food safety, environmental monitoring 
and bioanalysis can all benefit from the advantages of a SRM analysis. Therefore, 
costly sample preparation procedures can be optimized to deliver an efficient lab 
oratory workflow.  
Moreover, one can measure 50–100 analytes in parallel in the same LC-SRM run if a 
reasonable duty cycle for accurate quantification and a sufficient dwell time to 
maintain a low limit of detection are applied. Upon identity confirmation, the 
primary transitions are used to quantify the analyte. This approach has the potential 
to dramatically increase the multiplexing capabilities of SRM. 
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